<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_5T3aQpH">Investigating the Prevalence of Reactive Online Searching in the COVID-19 Pandemic: Infoveillance Study</title>
				<funder ref="#_Na9YF5u">
					<orgName type="full">South West Biosciences Doctoral Training Partnership</orgName>
				</funder>
				<funder>
					<orgName type="full">Cardiff University</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/501100000866</idno>
				</funder>
				<funder ref="#_VAjY59e">
					<orgName type="full">BBSRC</orgName>
				</funder>
				<funder>
					<orgName type="full">Idorsia Pharmaceuticals</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/501100016198</idno>
				</funder>
				<funder>
					<orgName type="full">Biotechnology and Biological Sciences Research Council</orgName>
					<orgName type="abbreviated">BBSRC</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/501100000268</idno>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Rafael</forename><forename type="middle">A</forename><surname>Badell-Grau</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> School of Biosciences , Cardiff University , Cardiff , United Kingdom</note>
								<orgName type="department">School of Biosciences</orgName>
								<orgName type="institution">Cardiff University</orgName>
								<address>
									<settlement>Cardiff</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jordan</forename><surname>Patrick Cuff</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> School of Biosciences , Cardiff University , Cardiff , United Kingdom</note>
								<orgName type="department">School of Biosciences</orgName>
								<orgName type="institution">Cardiff University</orgName>
								<address>
									<settlement>Cardiff</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>BSc, MRes</roleName><forename type="first">Brendan</forename><forename type="middle">P</forename><surname>Kelly</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> School of Biosciences , Cardiff University , Cardiff , United Kingdom</note>
								<orgName type="department">School of Biosciences</orgName>
								<orgName type="institution">Cardiff University</orgName>
								<address>
									<settlement>Cardiff</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MS</roleName><forename type="first">Helen</forename><surname>Waller-Evans</surname></persName>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Medicine Discovery Institute , Cardiff University , Cardiff , United Kingdom</note>
								<orgName type="department">Medicine Discovery Institute</orgName>
								<orgName type="institution">Cardiff University</orgName>
								<address>
									<settlement>Cardiff</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><roleName>BSc, PGDip, DPhil</roleName><forename type="first">Emyr</forename><surname>Lloyd-Evans</surname></persName>
							<email>lloyd-evanse@cardiff.ac.uk</email>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> School of Biosciences , Cardiff University , Cardiff , United Kingdom</note>
								<orgName type="department">School of Biosciences</orgName>
								<orgName type="institution">Cardiff University</orgName>
								<address>
									<settlement>Cardiff</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><surname>Mbiochem</surname></persName>
						</author>
						<author>
							<persName><surname>Dphil</surname></persName>
						</author>
						<author>
							<affiliation key="aff2">
								<note type="raw_affiliation">School of Biosciences Cardiff University Sir Martin Evans Building Museum Avenue Cardiff , CF10 3AX United Kingdom</note>
								<orgName type="department">School of Biosciences</orgName>
								<orgName type="institution">Cardiff University Sir Martin</orgName>
								<address>
									<addrLine>Evans Building Museum Avenue</addrLine>
									<postCode>CF10 3AX</postCode>
									<settlement>Cardiff</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_3u9GB6N">Investigating the Prevalence of Reactive Online Searching in the COVID-19 Pandemic: Infoveillance Study</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">017C508FE11F6E1637536F1A954EC6A0</idno>
					<idno type="DOI">10.2196/19791</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T11:45+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term xml:id="_94kJXHH">chloroquine</term>
					<term xml:id="_9VWSkSG">coronavirus</term>
					<term xml:id="_CgJPYWn">COVID-19</term>
					<term xml:id="_m4RhQdZ">fake news</term>
					<term xml:id="_dXHmf3C">Google Trends</term>
					<term xml:id="_9cARnZx">ibuprofen</term>
					<term xml:id="_hEjkzZ7">infodemiology</term>
					<term xml:id="_FuPQqRM">misinformation</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_5Pv6XAq">Background:</head><p xml:id="_CcEGeXZ"><s xml:id="_6CNCDZv">The ongoing pandemic has placed an unprecedented strain on global society, health care, governments, and mass media.</s><s xml:id="_5MV6peM">Public dissemination of government policies, medical interventions, and misinformation has been remarkably rapid and largely unregulated during the COVID-19 pandemic, resulting in increased misinterpretations, miscommunication, and public panic.</s><s xml:id="_Aq9Wucf">Being the first full-scale global pandemic of the digital age, COVID-19 has presented novel challenges pertinent to government advice, the spread of news and misinformation, and the trade-off between the accessibility of science and the premature public use of unproven medical interventions.</s></p><p xml:id="_gr824MB"><s xml:id="_JqYHGQ3">Objective: This study aims to assess the use of internet search terms relating to COVID-19 information and misinformation during the global pandemic, identify which were most used in six affected countries, investigate any temporal trends and the likely propagators of key search terms, and determine any correlation between the per capita cases and deaths with the adoption of these search terms in each of the six countries.</s></p><p xml:id="_sCrWkxj"><s xml:id="_Ghhpf3B">Methods: This study uses relative search volume data extracted from Google Trends for search terms linked to the COVID-19 pandemic alongside per capita case and mortality data extracted from the European Open Data Portal to identify the temporal dynamics of the spread of news and misinformation during the global pandemic in six affected countries (Australia, Germany, Italy, Spain, the United Kingdom, and the United States).</s><s xml:id="_dqbmm3d">A correlation analysis was carried out to ascertain any correlation between the temporal trends of search term use and the rise of per capita mortality and disease cases.</s></p><p xml:id="_ACmUAWU"><s xml:id="_BDkdKSX">Results: Of the selected search terms, most were searched immediately following promotion by governments, public figures, or viral circulation of information, but also in relation to the publication of scientific resources, which were sometimes misinterpreted before further dissemination.</s><s xml:id="_n3U2bGN">Strong correlations were identified between the volume of these COVID-19-related search terms (overall mean Spearman rho 0.753, SD 0.158), and per capita mortality (mean per capita deaths Spearman rho 0.690, SD 0.168) and cases (mean per capita cases Spearman rho 0.800, SD 0.112).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_TSrFf3r">Conclusions:</head><p xml:id="_PPvhjmQ"><s xml:id="_rgUaC4d">These findings illustrate the increased rate and volume of the public consumption of novel information during a global health care crisis.</s><s xml:id="_vCWPdCy">The positive correlation between mortality and online searching, particularly in countries with lower COVID-19 testing rates, may demonstrate the imperative to safeguard official communications and dispel misinformation in these countries.</s><s xml:id="_KNqQYAD">Online news, government briefings, and social media provide a powerful tool for the dissemination of important information to the public during pandemics, but their misuse and the presentation of misrepresented medical information should be monitored, minimized, and addressed to safeguard public safety.</s><s xml:id="_gUG5uqX">Ultimately, governments, public health authorities, and scientists have a moral imperative to safeguard the truth and maintain an accessible discourse with the public to limit fear.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="11" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="12" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="13" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="14" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="15" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="16" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="17" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_p8czsRC">Introduction</head><p xml:id="_T8PV3KK"><s xml:id="_DDg8kN6">The COVID-19 pandemic has encouraged an unprecedented international panic.</s><s xml:id="_Kwz27Kb">Since its emergence in late 2019 in the Hubei Province of China, COVID-19 has spread worldwide, and its associated infectivity and death rate have challenged world leaders, health care systems, and the public <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b1">2]</ref>.</s><s xml:id="_bqpaKqZ">Unlike comparable previous pandemics, such as the Spanish flu in 1918, the internet has provided to the public a source of connectivity and a means to rapidly acquire emerging information about the virus <ref type="bibr" target="#b0">[1]</ref>.</s><s xml:id="_kGG2du3">The information available is, however, not always verifiable or scientifically supported.</s></p><p xml:id="_nrNfEEn"><s xml:id="_hxZXQWe">The dissemination of government policy and cutting-edge medical research is unquestionably important in the remit of a global pandemic, but misinterpretation is commonplace.</s><s xml:id="_fV4G2Ws">The desperation of the public encourages the opportunistic adoption of unverified medical interventions.</s><s xml:id="_PUKjcjq">The misuse and misrepresentation of such information presents a critical challenge to governments and to the public.</s><s xml:id="_R2x5VUE">Equally, the public may seek out and enable misinformation (eg, the virus being spread by 5G towers <ref type="bibr" target="#b2">[3]</ref>), which is rapidly distributed via social media <ref type="bibr" target="#b3">[4]</ref>.</s><s xml:id="_ucGFNWF">The increased dependence of the public on social media and other inherently biased sources of information may inflate the rate at which misinformation spreads, possibly fostering disenfranchisement with government and health care organizations <ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref>.</s><s xml:id="_WazxaUP">This could ultimately provoke disregard toward restrictions enforced for public safety, lead to reduced supplies of medicines and personal protective equipment (PPE), or potentially even to reduced medical engagement and worsening of chronic conditions, increasing pressure on already strained health care providers.</s></p><p xml:id="_BZchc2t"><s xml:id="_HQhf2v5">Given the rapid flow of digital information during the COVID-19 pandemic, real-time data collection and analysis provides an unparalleled opportunity to assess the public response to information as it emerges.</s><s xml:id="_FjsnpSz">Through internet-derived information from social media, news, and search engine use, public reactions and perceptions can be assessed in real time <ref type="bibr" target="#b3">[4,</ref><ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref>.</s><s xml:id="_62GSTV4">Google Trends (GT) has been used for not only the analysis of epidemiologically relevant data regarding influenza <ref type="bibr" target="#b8">[9]</ref> and disease outbreaks <ref type="bibr" target="#b9">[10]</ref> but also, more recently, COVID-19 <ref type="bibr" target="#b10">[11]</ref>.</s><s xml:id="_HTqf5bp">By assessing the temporal dynamics of search terms related to the pandemic, particularly those relating to misinformation, it is possible to infer likely sources, propagators, and impacts.</s><s xml:id="_Nt7n4hC">This study employs GT for the analysis of search terms used during the COVID-19 pandemic relating to government policy, potential treatments, and misinformation, specifically in three English and three non-English speaking countries: Australia, the United Kingdom, the United States, Germany, Italy, and Spain.</s><s xml:id="_UFqQfbG">The aims of this study are to identify any correlation between the relative search volumes (RSVs) for information relating to the first wave of the pandemic, and to discuss these search volumes in the context of emerging news, alongside the prevalence of cases and deaths in each of the six focal countries.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_hjgtQWd">Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_FVfxGda">Mortality, Case, and Testing Data Extraction</head><p xml:id="_RmHdr7k"><s xml:id="_dcXQnMU">Worldwide mortality and case data, and country population sizes were extracted from the European Union Open Data Portal <ref type="bibr" target="#b11">[12]</ref> on April 17, 2020 (Figure <ref type="figure" target="#fig_0">1</ref>).</s><s xml:id="_ZWwCsXA">Data were retained only for the six focal countries.</s><s xml:id="_RKPHbrT">Dates for which no data were available from November 1, 2019, to the first recorded numbers for that country were marked as zero.</s><s xml:id="_jnPaWqw">Per capita cases and deaths were also calculated using the included population sizes and retained for later analyses and figures.</s><s xml:id="_hqgprCc">Per capita values, although not widely reported by the media at this time, were used in this study to correct for the large variation in population sizes of the focal countries, and to better represent the proportional pressure upon each country.</s></p><p xml:id="_2BmjCJy"><s xml:id="_99xzEQK">The objective reliability of these data is questionable given the internationally variable extent of testing and the resultant predicted inaccuracy of the case numbers in each country.</s><s xml:id="_bZ7BGJk">International variations in the definition of COVID-19-related deaths and failures to report the full extent of case numbers also warrant skepticism.</s><s xml:id="_aDNSv8m">In the remit of this study, however, these data represent the immediate perceived threat and pressure elicited upon the societies of each focal country, thus providing a suitable comparison against the temporal dynamics of the search terms used.</s><s xml:id="_xqqWpa4">The numbers of COVID-19 tests per thousand citizens were downloaded from Our World in Data <ref type="bibr" target="#b12">[13]</ref>; given the irregularity of testing and resultant unavailability of data for some countries, these data were not used for correlation analysis.</s><s xml:id="_hCQYxUF">The number of tests completed by April 17, 2020, was recorded, except for Germany and Spain for which values represented the tests per thousand completed by April 19 and 13, respectively, due to a lack of data for April 17.</s><s xml:id="_MXJB6rd">Testing data represent the number of tests performed, rather than the number of individuals tested, given the wider availability of these data; the nature of Australia's testing units is, however, unclear.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_YDG9dx5">Search Volume Data Extraction</head><p xml:id="_PW23qTE"><s xml:id="_WuXSFfU">Data were extracted from GT on April 17, 2020, for the period of November 1, 2019, to April 17, 2020, which includes a brief period before the first confirmed case of COVID-19 for comparison.</s><s xml:id="_EXcbqvS">These data provide a proxy for public interest in government policy, emerging health care interventions, and misinformation, later contextualized as a response to the release of such information.</s><s xml:id="_h6smsYV">The data extracted from GT are RSVs for predetermined search terms, allowing comparison of search rates for different terms via Google, the most widely used internet search engine, especially in the countries selected <ref type="bibr" target="#b13">[14,</ref><ref type="bibr" target="#b14">15]</ref>.</s><s xml:id="_CUwNAzh">These RSVs are presented for each date of a given time period within a given country.</s><s xml:id="_z4uBKud">Data are normalized relative to the highest RSV peak in that time period (this peak represented as 100).</s></p><p xml:id="_Bt5UQVE"><s xml:id="_pMTqu2g">Data were extracted for searches generated from Australia, Germany, Italy, Spain, the United Kingdom, and the United States.</s><s xml:id="_Gs2pSDp">These countries were selected due to their widespread use of Google (precluding China and many other Asiatic countries), variation in the extent to which they were impacted by the pandemic, nuances in their responses to the pandemic, and the accessibility of their news and media in one predominant language.</s><s xml:id="_DXczczB">All search terms were preceded by "coronavirus" to ensure relevance to the pandemic; "coronavirus" was selected over "COVID19" and similar terms due to its greater prevalence of searches (eg, in the United States, "coronavirus vaccine" yielded four-fold the search volume of "corona vaccine" and "covid vaccine", and twenty-fold that of "covid19 vaccine" and "covid-19 vaccine").</s></p><p xml:id="_VArSE2q"><s xml:id="_CGFC3Bk">All search terms were selected based on their widespread media coverage and their high Google search volumes.</s><s xml:id="_4DX7uYE">Their placement in the broad categories of government policy, medical interventions, and misinformation were based on the context of their wide reporting by media, government, research, and health care organizations of those particular countries.</s><s xml:id="_Eqwj8wb">The designation of search terms as medical interventions did not equate to their effectiveness in treating COVID-19 but scientific discussion around, or political endorsement of, their experimental or genuine use in treating the virus.</s><s xml:id="_2B3Bbyv">Chloroquine, for example, was not empirically shown to benefit patients at the time of this study, and its early endorsement during the pandemic largely emanated from the United States, but international research nonetheless endeavored to ascertain any benefit it conferred to patients with COVID-19, this being the primary focus of its initial widespread news coverage.</s><s xml:id="_nAVZ8cB">Misinformation search terms were labeled as such when there was no empirical evidence nor active published peer-reviewed research regarding their relevance to COVID-19, and their media coverage indicative of their potential for controversy; such search terms could often be traced back to an initial misinterpretation or false statement, some of which are highlighted in the discussion.</s><s xml:id="_KfCzsfS">All terms were identified as COVID-19 misinformation by Dhillon et al <ref type="bibr" target="#b15">[16]</ref>.</s><s xml:id="_XAETXR3">Other search terms relevant to COVID-19 were considered but for a contained and meaningful statistically significant comparison only those with relatively high and comparable RSVs within the three aforementioned categories were included.</s><s xml:id="_9yV3zQJ">Search terms for which variations were possible (eg, chloroquine vs hydroxychloroquine) were included as the variation with the greatest GT search volume with the simpler terminology routinely having the greatest search volume.</s></p><p xml:id="_utvujNS"><s xml:id="_vJysfSD">Searches were carried out in the language native to each country unless the English terms provided a greater number of results (ie, where English phraseology was adopted).</s><s xml:id="_7S6aADe">Searches were carried out in batches to identify relative differences in search volumes, with three batches coarsely defined as "government policies," "medical interventions," and "misinformation."</s><s xml:id="_4WfBQHe">All search batches contained "coronavirus chloroquine" as a standard to facilitate some comparison between categories given its relatively central positioning in most batches.</s><s xml:id="_n4EeREc">Chloroquine was selected for its relatively average search volume across countries and categories, acting as an anchor to facilitate visual comparison between higher and lower RSVs.</s><s xml:id="_4XCd994">The search term RSVs were all also individually downloaded (independently normalized with the highest peak being 100) for subsequent correlation analysis to evenly represent the extent of searching and focus on the temporal dynamics.</s><s xml:id="_3J53SRS">Given the representation of numbers less than one as "&lt;1" by GT, all RSVs of "&lt;1" were converted to 0.5 to facilitate quantitative comparison.</s></p><p xml:id="_4RUjpWC"><s xml:id="_dG6g6BU">The government policy search terms comprised chloroquine (control standardization term), social distancing, sanitizer, mask, isolation, gloves, and testing (Textbox 1).</s><s xml:id="_AtUAPwW">Social distancing was implemented by many countries as an early and maintained means to prevent viral spread, as was isolation, although the latter may also have been searched in association with the well-being and mental health consequences of reduced social contact during lockdown.</s><s xml:id="_FgAFxM3">The use of sanitizer for cleansing of hands was also encouraged by governments throughout the pandemic, although depleting public availability in most countries led many to attempt to create homemade sanitizer <ref type="bibr">[17]</ref>.</s><s xml:id="_VSxwXR2">Masks and gloves were employed as a protective means to prevent spread, although predominantly by frontline health care workers; public purchase of this PPE was problematic in many countries, resulting in reduced availability for medical practitioners <ref type="bibr" target="#b16">[18,</ref><ref type="bibr" target="#b17">19]</ref>.</s><s xml:id="_AMd6RuV">Testing and tracing was carried out for coronavirus, but the extent of testing and the national focus on its importance varied internationally <ref type="bibr" target="#b12">[13]</ref>.</s><s xml:id="_5da6SeC">The US spelling of "sanitizer" was maintained for the UK searches given a higher prevalence than the UK spelling "sanitiser."</s><s xml:id="_FxUYjWR">Due to the GT search limit, the government policy search was split into two batches (batch 1: chloroquine, social distancing, sanitizer, mask, and isolation, and batch 2: chloroquine, gloves, and testing, with linguistic variations for Germany, Italy, and Spain).</s></p><p xml:id="_HkkFEE8"><s xml:id="_ntBhxa7">Textbox 1. Google Trends search terms used in each of the three categories.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_rpfSFdJ">Government policy</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_57uKZQk">•</head><p xml:id="_6kZPpTx"><s xml:id="_mqJEear">Australia, the United Kingdom, and the United States: social distancing, sanitizer, mask, isolation, gloves, testing</s></p><p xml:id="_4S6FrQd"><s xml:id="_6pdVZAx">• Germany: social distancing, desinfektion-smittel, maske, isolation, handschuhe, testen • Italy: distanziamento sociale, disinfettante, maschera, isolamento, guanti, analisi • Spain: distanciamiento social, desinfectante, mascara, aislamiento, guantes, pruebas Medical interventions • Australia, the United Kingdom, and the United States: chloroquine, remdesivir, paracetamol, vaccine, ibuprofen • Germany: chloroquin, remdesivir, paracetamol, impstoff, ibuprofen • Italy: chlorochina, remdesivir, paracetamolo, vaccino, ibuprofene • Spain: cloroquina, remedsivir, paracetamol, vacuna, ibuprofeno Misinformation • Australia, the United Kingdom, and the United States: 5G, man made, lab • Germany: 5G, hergestellt, labor • Italy: 5G, creato, laboratorio • Spain: 5G, creado, laboratorio</s></p><p xml:id="_Q2x2PQS"><s xml:id="_f7QujTW">The medical intervention search terms comprised chloroquine (control standardization term), remdesivir, paracetamol, vaccine, and ibuprofen (Textbox 1).</s><s xml:id="_5zSpKTa">All of these search terms pertain to treatments that were suggested to have potential effects against COVID-19 symptoms.</s><s xml:id="_MUnzNvZ">The public focus on vaccines reflected the ongoing development of vaccines and the desire for relief from the pandemic <ref type="bibr" target="#b18">[20]</ref>.</s><s xml:id="_7tHnwwV">Paracetamol and ibuprofen were used to subdue pain associated with COVID-19 symptoms, but public perception became antagonistic toward using ibuprofen for COVID-19 symptoms, which shifted focus toward paracetamol <ref type="bibr" target="#b19">[21]</ref>.</s></p><p xml:id="_rNpxCnW"><s xml:id="_xY9C57E">The misinformation search terms comprised chloroquine (control term), 5G, man made, and lab (Textbox 1).</s><s xml:id="_v47WR3q">These search terms pertain to internationally prevalent misinformation related to COVID-19, often specifically suggesting a disingenuous cause or source of the viral spread.</s><s xml:id="_Cynf7cr">Specifically, these entail theories that the virus was being spread by the new 5G phone masts, that the virus was manufactured, and that the virus was released from a laboratory <ref type="bibr" target="#b2">[3,</ref><ref type="bibr" target="#b15">16,</ref><ref type="bibr" target="#b20">[22]</ref><ref type="bibr" target="#b21">[23]</ref><ref type="bibr" target="#b22">[24]</ref>, all of which have subsequently been debunked <ref type="bibr" target="#b23">[25]</ref><ref type="bibr" target="#b24">[26]</ref><ref type="bibr" target="#b25">[27]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_uUTRWy6">Statistical Analysis</head><p xml:id="_wq9M27U"><s xml:id="_5qCCCuT">Statistical analyses and plotting of data were carried out using R version v4.0.0 (R Foundation for Statistical Computing) <ref type="bibr" target="#b26">[28]</ref>.</s><s xml:id="_rVStAfd">Line graphs were created for per capita cases and deaths, and a bar chat for tests per thousand citizens using ggplot in the ggplot2 package version 3.3.0 in R <ref type="bibr" target="#b27">[29]</ref>, with colors assigned via the RColorBrewer package v1.1-2 <ref type="bibr" target="#b28">[30]</ref>.</s><s xml:id="_MFMbkPe">The data were identified as nonnormally distributed via Shapiro-Wilk tests, so nonparametric statistical analyses were selected.</s><s xml:id="_KNvCzZX">Correlations between RSVs and per capita deaths and cases were tested using Spearman rho rank correlation via the rcor function of the Hmisc package version 4.4-0 <ref type="bibr" target="#b29">[31]</ref>.</s><s xml:id="_K6zyAWa">The output was then presented in a correlogram via the corrplot function of the corrplot package version 0.84 <ref type="bibr" target="#b30">[32]</ref>, with colors assigned via the viridis package v0.5.1 <ref type="bibr" target="#b31">[33]</ref>.</s><s xml:id="_y9gkBKC">Line graphs were created for each of the three categories of search terms for each country to aid comparison of both the extent and temporality of RSV trends in GraphPad Prism version 8 (GraphPad Software) <ref type="bibr">[34]</ref>.</s><s xml:id="_QPY4vkd">All statistical data is included in Multimedia Appendix 1.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_uWXx4JS">Information Sources and Reliability</head><p xml:id="_j2zScSf"><s xml:id="_U2FN3tx">The sources for the non-search term data (The European Union Open Data Portal and Our World in Data) are reputable sources that derive their data from official national reports, scientific publications, and other reliable sources.</s><s xml:id="_M5WTRpf">The data extracted from these sources align with those published internationally in response to the pandemic situation as it develops.</s><s xml:id="_eEMRNrP">The GT data are collected and presented by Google based on the input of users of their service, thus should be fully reliable.</s><s xml:id="_UMSAFJP">Although most sources cited in this report are from reputable scientific, government, or public health authority sources, others discussed throughout the manuscript are taken from mass media, social media, and other heavily biased sources or from scientific articles that discuss such sources; these sources are being referred to on the basis of these biases or simply to refer to the temporal development and emergence of global news, for which bias in an important factor.</s><s xml:id="_SCdzYQG">The paper discusses the reporting of this information in an objective manner, with no subscription to the reported ideals or beliefs represented in the text.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_qzFrGhr">Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_NdUT63w">Mortality, Case, and Test Results</head><p xml:id="_j3mweGJ"><s xml:id="_Wha5UTV">All countries show similar per capita case (Figure <ref type="figure" target="#fig_1">2</ref>) and death (Figure <ref type="figure" target="#fig_2">3</ref>) trends temporally, with both beginning to exponentially increase in most countries between late February and early March.</s><s xml:id="_E4m5ptB">Of the six countries, Italy was the first to present a substantial number of cases and deaths (mid-February 2020).</s><s xml:id="_XyKptkv">Australia, the United Kingdom, and the United States were the last to experience rapidly increasing per capita case numbers (~March 10).</s><s xml:id="_eS2umxn">The per capita case number trends are relatively similar in their extents for most countries, except for Spain, which exhibits approximately 50% more peak per capita cases than the second highest peak, the United Kingdom (Spain: 0.01937, UK: 0.013113), and Australia, which exhibits approximately a quarter of the peak per capita cases for the majority of the countries (Australia: 0.002445, average for other countries, excluding Spain: 0.010603, SD 0.0023).</s><s xml:id="_UxHMRH8">The per capita deaths similarly increase last for Australia, the United Kingdom, the United States, and Germany.</s><s xml:id="_QgGh4Vb">Germany and the United States display a shallower trajectory of per capita death increases, and Australia shows a minor peak of per capita deaths.</s><s xml:id="_XMrcDcE">Spain again exhibits the greatest peak of per capita deaths, but only with an approximate 30% increase over the peaks of Italy, the United Kingdom, and the United States (Spain: 0.002033, Italy: 0.001607, the United Kingdom: 0.001474, the United States: 0.001506), compared to the ~50% increase over the second highest peak for per capita cases.</s></p><p xml:id="_rKjMtYJ"><s xml:id="_w5HTNCm">Testing for COVID-19 varied massively between countries, with Germany showing the highest tests per thousand, with around 25 tests per thousand, and the United Kingdom showing the lowest with around 6.5 tests per thousand (Figure <ref type="figure" target="#fig_3">4</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_PZ33H3g">Search Volume Results</head><p xml:id="_Qm4JEMG"><s xml:id="_9Fj3nWc">Of the government policy search terms (Figure <ref type="figure" target="#fig_4">5</ref>), "testing" was prevalent in all countries, and "isolation" relatively high in all but the United States and Germany.</s><s xml:id="_DXDAZd6">"Sanitizer" was highly searched in Germany, Italy, and Spain.</s><s xml:id="_yDrqMxt">"Masks" was highly searched in Australia, Germany, Italy, and the United States, and to a lesser extent the United Kingdom.</s><s xml:id="_RXgBhfh">"Gloves" was searched less in all but Italy and Spain.</s><s xml:id="_NejAmFb">"Social distancing" was searched less except in Australia and the United Kingdom, where this term was the third most searched.</s><s xml:id="_umMezsJ">Most search terms peaked at a similar time (mid-March) in most countries, although "mask" also peaked in late January to early February in Australia, the United Kingdom, and the United States, and to a lesser extent in Germany and Italy.</s><s xml:id="_yTX2cxT">In Germany and Italy, "sanitizer" and "mask" peaked in early March, 2-3 weeks earlier than a later peak coinciding with that of "testing" in other countries.</s><s xml:id="_yvW9WwY">In the United States, "gloves" was searched most at the end of February, but also with a second peak in early April, unlike the other countries.</s><s xml:id="_3etaJmm">In Italy, searches of "testing" peaked sporadically from late February to mid-April (the end of the search period), with larger peaks spread further across the period.</s></p><p xml:id="_GXDUcR9"><s xml:id="_VCCs8tB">Of the medical intervention search terms (Figure <ref type="figure" target="#fig_5">6</ref>), "vaccine" was highly searched in all countries, peaking in late March, except in Germany, where it peaked in late February, and Italy, where it peaked sporadically from the end of January to mid-April (the end of the search period).</s><s xml:id="_ZS6KjG2">In the United Kingdom, "vaccine" had a second peak in mid-April.</s><s xml:id="_SjUBW8D">The other medical interventions had relatively small peaks, often in mid-or late March.</s><s xml:id="_T2dV8j6">"Remdesivir" peaked higher in Italy relative to the other countries.</s><s xml:id="_xedhtZ6">"Chloroquine" peaked much higher in the United States relative to the other countries, also having a smaller peak in the United Kingdom.</s><s xml:id="_gNZQUAE">"Ibuprofen" had the highest peak in Germany and the United Kingdom, peaking in all countries in mid-or late March and having a second peak in early April in the United States.</s></p><p xml:id="_ZHy9kNN"><s xml:id="_n5Yaeak">Of the misinformation search terms (Figure <ref type="figure">7</ref>), "5G" had erratic smaller peaks throughout mid-and late March but peaked in most countries in early April, with Germany and Spain displaying reduced peaks.</s><s xml:id="_xb3j6dq">"Man made" was mostly searched in mid-March, with some more widespread erratic peaks in all but the United Kingdom, and a substantial peak in late January and early February in Australia, Italy, and Spain.</s><s xml:id="_Kx7kjfG">"Lab" was searched relatively little in Australia, the United Kingdom, and, to some extent, the United States.</s><s xml:id="_YpK4xH4">"Lab" was, however, highly searched in Italy and Spain in late March, with Italy also exhibiting large peaks in late January and late February, and was searched at similar intervals in Germany but never so proportionally high as Italy and Spain.</s><s xml:id="_PjmyJUW">In most cases, peaks of "lab" coincide with peaks of "man made."</s><s xml:id="_gqtN5JQ">Grouped RSV data, normalized to the highest RSV peak in the time period (represented as 100) were extracted from GT on April 17, 2020, for the period of November 1, 2019, to April 17, 2020.</s><s xml:id="_hgrdjpd">Search terms included "coronavirus chloroquine" (control term), "coronavirus social distancing," "coronavirus sanitizer," "coronavirus mask," "coronavirus isolation," "coronavirus gloves," and "coronavirus testing," with variations to reflect the language native to each country.</s><s xml:id="_Jp8HfEA">Search terms included "coronavirus chloroquine," "coronavirus remdesivir," "coronavirus paracetamol," "coronavirus vaccine," and "coronavirus ibuprofen," with variations to reflect the language native to each country.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_kTuEFrK">Figure 7.</head><p xml:id="_jwpqhec"><s xml:id="_WuBEhmh">Misinformation relative search volumes (RSVs) extracted from Google Trends (GT).</s><s xml:id="_VSHSe6h">Grouped RSV data, normalized to the highest RSV peak in the time period (represented as 100) were extracted from GT on April 17, 2020, for the period of November 1, 2019, to April 17, 2020.</s><s xml:id="_NkgnTka">Search terms included "coronavirus chloroquine," "coronavirus remdesivir," "coronavirus paracetamol," "coronavirus vaccine," and "coronavirus ibuprofen," with variations to reflect the language native to each country.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Pzvfq5W">Correlation Analysis Results</head><p xml:id="_eS9pbFC"><s xml:id="_fp5BNEr">In all countries, almost all normalized search terms significantly positively correlated with one another (overall mean Spearman rho 0.753, SD 0.158) and per capita deaths (mean per capita deaths Spearman rho 0.690, SD 0.168) and cases (mean per capita cases Spearman rho 0.800, SD 0.112; Figure <ref type="figure" target="#fig_6">8</ref>, Table <ref type="table" target="#tab_1">1</ref>, and Multimedia Appendix 1 Table <ref type="table" target="#tab_1">S1</ref>); the only exception was the nonsignificant association between per capita deaths and remdesivir RSV in Australia (Spearman rho 0.134, P=.08).</s></p><p xml:id="_JjQxBJr"><s xml:id="_6TFGMn3">Overall, stronger correlations were identified more universally for the United Kingdom (mean Spearman rho 0.851, SD 0.066) and the United States (mean Spearman rho 0.873, SD 0.058), while relatively weaker correlations were shown for Australia (mean Spearman rho 0.641, SD 0.150) and Germany (mean Spearman rho 0.632, SD 0.157; Figure <ref type="figure" target="#fig_6">8</ref>, Table <ref type="table" target="#tab_1">1</ref>, and Multimedia Appendix 1 Table <ref type="table" target="#tab_1">S1</ref>).</s><s xml:id="_63capWK">In Italy and Spain, the weakest correlations were those between social distancing and all other variables.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_9yuJdEB">Discussion</head><p xml:id="_36m2Qpz"><s xml:id="_GUQSKum">This study aims to identify any correlation between the internet searching of defined COVID-19-relevant search terms and the per capita cases and deaths in six countries.</s><s xml:id="_29nb33w">We identified a positive correlation between the cases and deaths relating to COVID-19 and online searches surrounding government policies, medical interventions, and scientific misinformation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_vcsTq53">Principal Results</head><p xml:id="_qgFRkjS"><s xml:id="_x4djgZZ">Between November 1, 2019 and April 17, 2020, per capita deaths and cases showed a similar trend across the six countries, with all having reached or passed peak daily new cases during the first wave of the pandemic.</s><s xml:id="_z7VkCzn">However, Australia and Germany experienced fewer deaths during this time period, allowing for a direct comparison of the search trends across countries with high and low COVID-19 cases and deaths.</s><s xml:id="_4JqAKEX">Where the ratio of mortality to cases is higher, such as the United Kingdom, which had the highest excess deaths in Europe during this period <ref type="bibr" target="#b32">[35]</ref>, this could reflect strained health care provision, delayed or reduced effectiveness of preventative measures, a poorer testing effort, or a combination of all of these <ref type="bibr" target="#b33">[36,</ref><ref type="bibr" target="#b34">37]</ref>.</s><s xml:id="_y8FAgyG">Disparity in testing across countries may also have exacerbated differences in mortality.</s><s xml:id="_AhSnpuK">The importance of testing is illustrated by its high RSV across all countries (Figure <ref type="figure" target="#fig_4">5</ref>) and the finding that the greatest degree of testing (Germany) aligns with relatively low mortality and weak correlations between RSVs and caseload.</s><s xml:id="_d6GqR6g">Where testing and contact tracing have been employed (eg, Germany, South Korea), they have been undoubtedly effective in mitigating increases in cases and deaths <ref type="bibr" target="#b35">[38,</ref><ref type="bibr" target="#b36">39]</ref>, possibly leading to an increased media and public interest, predominantly, it seems, in countries where it is lacking.</s></p><p xml:id="_BQrQbTf"><s xml:id="_YgTq98w">Overall, stronger correlations were observed in the United Kingdom and the United States.</s><s xml:id="_Pf2H49h">The English-speaking majority of these countries could explain this, given the widespread use of English on social media and in international news.</s><s xml:id="_EGVAn6W">In direct contrast, Australia had some of the weakest overall correlations; the combined low per capita deaths and cases, and the earlier application of travel restrictions and a 2 week quarantine <ref type="bibr" target="#b37">[40,</ref><ref type="bibr">41]</ref> may have fostered a greater sense of safety and, therefore, less need by individuals to focus on the pandemic, evidenced by reduced interest in medical interventions.</s><s xml:id="_t3nGB5U">The overall strength of correlations being weakest in Australia and Germany, where the case and death figures are lower, supports the association between reduced public pressure and a less coordinated uptake of news and misinformation.</s></p><p xml:id="_DAFfFPM"><s xml:id="_GG8cXbG">That, in almost all cases, per capita deaths and cases correlated with the search term RSVs further suggests a strong relationship between the pressure elicited upon the public and their receptibility to pandemic-related digital information.</s><s xml:id="_d52ZEmz">The virus was internationally recognized and regularly reported by January <ref type="bibr" target="#b1">[2]</ref>, with many of the proposed preventative measures and medical interventions being widely searched online before cases and deaths began to emerge (Figures <ref type="figure" target="#fig_4">5</ref> and <ref type="figure" target="#fig_5">6</ref>).</s><s xml:id="_jyEySSJ">The peak of most RSVs in mid-March, aligning approximately with peak per capita deaths and cases (Figures <ref type="figure" target="#fig_0">1</ref> and <ref type="figure" target="#fig_1">2</ref>), also coincides with the beginning of lockdown in many countries <ref type="bibr" target="#b39">[42]</ref>, suggesting that populations were well informed prelockdown and ready for substantial changes to living conditions.</s><s xml:id="_uFAdN3G">The more dramatic peaks of search term RSVs following the beginning of March may denote the public searching news-relevant topics in far greater volume due to their willingness to follow government guidance, increased anxiety, and free time.</s><s xml:id="_WEb8R5w">In Italy, however, RSV peaks arrived earlier, likely due to the earlier arrival of the virus.</s><s xml:id="_ZDUw3PH">The later peaks, which are often larger, may be propagated by greater exposure to mainstream and social media while at home and increased levels of anxiety (Multimedia Appendix 1 Figure <ref type="figure" target="#fig_0">S1</ref>) <ref type="bibr" target="#b40">[43,</ref><ref type="bibr" target="#b41">44]</ref> thus creating a "second wave."</s><s xml:id="_uxGJ7YE">This relatively erratic persistent search behavior, particularly surrounding misinformation, could indicate heightened public panic especially as per capita deaths increase.</s></p><p xml:id="_ZpPPqhq"><s xml:id="_8pHXUNq">The data in this study highlights the utility of infoveillance in assessing public readiness for and adoption of preventative measures.</s><s xml:id="_qKgyvhq">The early interest in masks observed in the United States and Australia could indicate a willingness for, or pre-emptive fear of, the use of PPE.</s><s xml:id="_WYvRekk">Despite some antimask sentiment in politicians <ref type="bibr" target="#b42">[45]</ref> and possible reluctance by governments to impose mask-wearing for fear of appearing dictatorial, the public may be more prepared for discourse surrounding PPE than expected given the high RSVs.</s><s xml:id="_66yYrVn">Conversely, social distancing consistently correlated weakly with other search terms, specifically in Germany, Italy, and Spain, despite all three countries entering nationwide lockdowns and observing government-mandated social distancing rules.</s><s xml:id="_XyCW5Ut">Given the use of translated search terms, where these received more searches than the English equivalent, this is unlikely to be due to linguistic differences, despite these comprising only the non-English-speaking countries.</s><s xml:id="_DrCxnTY">In some countries, strict enforcement of social distancing may not have been necessary due to greater compliance with guidelines (Germany).</s><s xml:id="_bcaVjuH">Alternatively, social distancing may not have been so heavily emphasized or adhered to in some countries, resulting in government-enforced curfews with fines for noncompliance, as experienced in Italy <ref type="bibr" target="#b43">[46,</ref><ref type="bibr" target="#b44">47]</ref>.</s><s xml:id="_kQjwJTQ">Regardless, clear and repeated guidance should be provided by governments to ensure compliance by their citizens.</s><s xml:id="_jRDp2KH">Good government response has been credited with the rapid reduction of lockdown measures in some countries, but such responses need to be data driven <ref type="bibr" target="#b35">[38,</ref><ref type="bibr" target="#b45">48]</ref>, and GT can provide an effective proxy for the extent of public adherence to this guidance.</s><s xml:id="_xjwcttg">Public interest in medical interventions was similarly moderately consistent between countries, with ibuprofen and chloroquine being the most searched.</s><s xml:id="_RvzbxCW">Some of this search intensity likely arose from misinformation, for example, the high RSVs for ibuprofen coincided with a scientific correspondence to The Lancet hypothesizing a heightened risk to a subset of patients with hypertension and diabetes should they take ibuprofen to combat COVID-19 <ref type="bibr" target="#b19">[21]</ref>.</s><s xml:id="_uNbmFTQ">This correspondence became misrepresented on messaging platforms and in media <ref type="bibr" target="#b15">[16,</ref><ref type="bibr" target="#b46">49]</ref> as "evidence" that ibuprofen worsened COVID-19 symptoms.</s><s xml:id="_F9uPUeY">Furthermore, a second ibuprofen RSV peak in April in the United States coincided with a viral social media message claiming that patients with COVID-19 using ibuprofen did not recover <ref type="bibr" target="#b15">[16]</ref>.</s><s xml:id="_uqyDXGF">The European Medicines Agency and the US Food and Drug Administration quickly discredited this as misinformation, possibly explaining the ephemerality of the RSV peak <ref type="bibr" target="#b23">[25,</ref><ref type="bibr" target="#b24">26]</ref>.</s><s xml:id="_X6k6mFU">Paracetamol was highly searched simultaneously with ibuprofen, suggesting that people were seeking alternatives <ref type="bibr" target="#b47">[50]</ref>.</s><s xml:id="_VCXwrxb">That the ibuprofen RSV comprises the highest medical intervention search peak in the United Kingdom and Germany, and a relatively high peak in other countries, compared to lower RSVs for experimental COVID-19 disease-modifying drugs such as remdesivir <ref type="bibr" target="#b48">[51]</ref>, confirms the capacity of misinformation to penetrate the public consciousness.</s><s xml:id="_rZ5s6ZB">Although this may also reflect the less familiar names and scientific background of the experimental drugs.</s><s xml:id="_phm7dcm">This is further evidenced by the much larger RSVs for vaccine across all countries, a term familiar with most people, yet a therapeutic option that is clearly much further from public availability than therapies such as remdesivir <ref type="bibr" target="#b49">[52]</ref>.</s><s xml:id="_qmRQqSn">The second peak of interest in vaccines in the United Kingdom was likely propagated by UK media reporting the initiation of clinical trials at the University of Oxford <ref type="bibr" target="#b50">[53]</ref>.</s><s xml:id="_5hhDF3Q">It is worth noting, however, that one experimental drug, namely, chloroquine, was searched with far greater intensity in the United States.</s><s xml:id="_vH9EAYr">This is likely due to US government briefings that supported chloroquine as a potential treatment for COVID-19 <ref type="bibr" target="#b51">[54]</ref> based on a small clinical study <ref type="bibr" target="#b52">[55]</ref>, which led to multiple larger studies that ultimately did not support the outcomes <ref type="bibr" target="#b52">[55,</ref><ref type="bibr" target="#b53">56]</ref> with most trials now suspended as reviewed in <ref type="bibr" target="#b54">[57]</ref> and following some reports of accidental self-poisoning <ref type="bibr" target="#b55">[58]</ref>.</s><s xml:id="_Kj6Buz9">The important role of clear guidance from government is further exemplified from the suggestion during US government briefings that consideration should be given to the internal use of disinfectant and UV light in combating COVID-19.</s><s xml:id="_NCa8Pnp">This is a clear example of misinformation arising from misinterpreted scientific literature that led to widescale panic and increased calls to poison centers <ref type="bibr" target="#b56">[59]</ref><ref type="bibr" target="#b57">[60]</ref><ref type="bibr" target="#b58">[61]</ref>.</s></p><p xml:id="_a6NSktG"><s xml:id="_aYfPKSg">Similarly, mass media and elected representatives have also propagated theories that SARS-CoV-2 is either man-made or was leaked from a laboratory in Wuhan.</s><s xml:id="_byQpS5u">A quickly retracted scientific preprint appeared to propagate this theory by providing it an undue sense of credibility <ref type="bibr" target="#b22">[24]</ref>.</s><s xml:id="_dVVBSz3">Although the man-made theory was scientifically discredited <ref type="bibr" target="#b25">[27]</ref>, public discussion moved toward a "leak" of the virus <ref type="bibr" target="#b15">[16,</ref><ref type="bibr" target="#b21">23]</ref>, highlighting the evolution and adaptability of misinformation, especially when supported by public figures <ref type="bibr" target="#b59">[62]</ref>.</s><s xml:id="_Hz25gRQ">Editors, reviewers, and authors should maintain stringent safeguards to ensure appropriate publishing, even of preprints, especially regarding such sensitive topics <ref type="bibr" target="#b60">[63]</ref>.</s><s xml:id="_U6rhMGN">Similar conspiracy theories with large RSVs (Figure <ref type="figure">7</ref>) arose via mainstream and social media outlets suggesting the spread of COVID-19 by 5G towers.</s><s xml:id="_EDHPP9f">The theory itself was in early circulation and despite being discredited as misinformation in January, long before the search intensity peaked <ref type="bibr" target="#b20">[22]</ref>, it led to vigilante attacks on phone masts and engineers in uninformed attempts to arrest viral spread <ref type="bibr" target="#b2">[3,</ref><ref type="bibr" target="#b15">16,</ref><ref type="bibr" target="#b20">22]</ref>.</s><s xml:id="_A7VmKzy">The danger of misguided intervention led by misinformation outlines a clear requirement for mechanisms to reduce the spread of, while rationally and widely discrediting, these theories via perceivably credible sources such as national governments or professional medical bodies <ref type="bibr" target="#b0">[1]</ref>.</s><s xml:id="_b3KdYW7">That the search volume surrounding 5G and ibuprofen dissipated so rapidly after documented attempts made by public health authorities such as the World Health Organization to curb the spread of this misinformation <ref type="bibr" target="#b23">[25,</ref><ref type="bibr" target="#b24">26]</ref> best illustrates this point.</s><s xml:id="_Mbudvfb">It is, therefore, clear that during this pandemic the consumption of mass media, social media, government announcements, and health organization releases has influenced the public perception around both the causes and treatments of COVID-19 and, as perhaps best evidenced by the high RSVs for ibuprofen and 5G, has contributed to both public panic and health care issues such as reduced stocks of essential medicines caused by stockpiling <ref type="bibr" target="#b47">[50]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Xa3CUDU">Limitations of GT Data</head><p xml:id="_muEHnBG"><s xml:id="_kXNXpNy">This study used GT data for six countries in which it is the most popular, but not the only, internet search engine.</s><s xml:id="_rhep8mh">However, as the most widely used, it provides the best snapshot of user searches so that appropriate statistical studies can be conducted.</s><s xml:id="_nFTkKmF">As with any searches, the data presented in this study do not confirm subscription of those searching the terms to the ideals, interventions, or policies that they represent; many of the queries that contribute to these data may have been submitted by critics and sceptics.</s><s xml:id="_8jXyxJY">Even such searches, however, ratify the increased public awareness, discussion, and spread of the information denoted by the search terms.</s><s xml:id="_gb2k7at">A greater volume of people reached by the information will undoubtedly suggest a greater number subscribing to the theories and ideas.</s><s xml:id="_gXpDs7w">The progression of a global pandemic is incredibly complicated and unpredictable, and the findings of this study focus on GT data from just one time period in a currently ongoing situation.</s><s xml:id="_peMjqqf">Although this study bears relevance primarily to the beginning of the pandemic, this is arguably the most critical point at which to limit spread; however, the findings may not prove as relevant to periods when the public have adjusted to the situation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_R5PHHNV">Conclusions</head><p xml:id="_nxtuvPf"><s xml:id="_dfu8wtH">Infoveillance has already proven to be a valuable tool during the COVID-19 pandemic through detection of novel symptoms <ref type="bibr" target="#b10">[11]</ref>, assessment of behaviors such as self-medication <ref type="bibr" target="#b61">[64]</ref>, and identification of outbreaks <ref type="bibr" target="#b62">[65]</ref>.</s><s xml:id="_uX64Rm2">This study focuses on the public response during the early developing pandemic, particularly surrounding misinformation, government policy, and medical interventions.</s></p><p xml:id="_nJt9rem"><s xml:id="_Et7gpF2">A study exploring the use of GT for digital epidemiology found that search term RSVs were influenced far more by media clamor than by epidemiological burden <ref type="bibr" target="#b63">[66]</ref>.</s><s xml:id="_EVSh5Z9">This pandemic is unique in that rapidly emerging medical research deposited in preprint archives has been accessible and consumed by the media and public pre-peer review, leading to potentially dangerous misinterpretation, as has occurred with chloroquine <ref type="bibr" target="#b55">[58]</ref>.</s><s xml:id="_a6muS7h">Although our findings ratify this, we also identified a positive correlation between internet searching and COVID-19 deaths and cases, indicating a more synergistic combined effect of epidemiological burden and media attention.</s><s xml:id="_UhePdX9">The prevalence and online spread of misinformation has been reported previously for COVID-19 <ref type="bibr" target="#b0">[1]</ref> with regard to social media platforms, and, as in this study, the findings ultimately identified an important role for public health organizations and governments in providing accessible online information and refutation of misinformation.</s><s xml:id="_HP6kupv">Medical misinformation has drastic health care consequences and pre-existing misinformation, particularly that surrounding vaccines, will be a significant future obstacle in overcoming COVID-19 <ref type="bibr" target="#b5">[6]</ref>.</s><s xml:id="_DzqYByU">The presentation of accurate information, including infodemiology data as illustrated in this study, to maintain societal ease is vital, and there is an imperative for scientists, public health authorities, and governments to collaborate to rigorously maintain this.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p xml:id="_H5jGyHY"><s xml:id="_DyeEbMb">Figure 1.</s><s xml:id="_SveURNF">Data extraction and workflow.</s></p></div></figDesc><graphic coords="3,56.69,82.33,481.91,255.22" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 .</head><label>2</label><figDesc><div><p xml:id="_wTmqQ9j"><s xml:id="_sVZkr37">Figure 2. Per capita cases of COVID-19 during the study period.</s></p></div></figDesc><graphic coords="5,56.69,451.06,481.86,289.12" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 3 .</head><label>3</label><figDesc><div><p xml:id="_kCfbbyj"><s xml:id="_P2WdaSk">Figure 3. Per capita COVID-19-related deaths during the study period.</s></p></div></figDesc><graphic coords="6,56.69,82.36,481.86,289.12" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 4 .</head><label>4</label><figDesc><div><p xml:id="_KVd6cJj"><s xml:id="_vzTwT5N">Figure 4. Total COVID-19 tests per thousand citizens in the six focal countries, as of April 17, 2020, except for Germany and Spain, which are represented by April 19 and 13, respectively, due to a lack of data for April 17.</s></p></div></figDesc><graphic coords="6,56.69,408.28,481.87,262.84" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 5 .</head><label>5</label><figDesc><div><p xml:id="_s4P4ygn"><s xml:id="_tDcTGUg">Figure5.</s><s xml:id="_GwY4fmN">Government policy relative search volumes (RSVs) extracted from Google Trends (GT).</s><s xml:id="_3ehjMw5">Grouped RSV data, normalized to the highest RSV peak in the time period (represented as 100) were extracted from GT on April 17, 2020, for the period of November 1, 2019, to April 17, 2020.</s><s xml:id="_RgmcAzv">Search terms included "coronavirus chloroquine" (control term), "coronavirus social distancing," "coronavirus sanitizer," "coronavirus mask," "coronavirus isolation," "coronavirus gloves," and "coronavirus testing," with variations to reflect the language native to each country.</s></p></div></figDesc><graphic coords="8,56.69,113.06,481.79,578.35" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Figure 6 .</head><label>6</label><figDesc><div><p xml:id="_vejb6Rg"><s xml:id="_BjxnMnE">Figure 6.</s><s xml:id="_2v5QHJm">Medical intervention relative search volumes (RSVs) extracted from Google Trends (GT).</s><s xml:id="_pVnuvpf">Grouped RSV data, normalized to the highest RSV peak in the time period (represented as 100) were extracted from GT on April 17, 2020, for the period of November 1, 2019, to April 17, 2020.Search terms included "coronavirus chloroquine," "coronavirus remdesivir," "coronavirus paracetamol," "coronavirus vaccine," and "coronavirus ibuprofen," with variations to reflect the language native to each country.</s></p></div></figDesc><graphic coords="9,56.69,112.96,481.87,578.45" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Figure 8 .</head><label>8</label><figDesc><div><p xml:id="_KEJVpeg"><s xml:id="_x3FfsFu">Figure 8. Correlograms for the search factors and per capita case and death rates for each country.</s><s xml:id="_pjs4FRA">The size of each circle indicates the strength of the correlation as does the color, denoted by the scale bar, with yellow and purple denoting positive and negative correlations, respectively.</s></p></div></figDesc><graphic coords="11,56.69,134.62,481.89,578.47" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 1 .</head><label>1</label><figDesc><div><p xml:id="_pU6P4r8"><s xml:id="_ngs8J83">Mean Spearman rho rank coefficients and their standard deviations are given for each country and overall results for all six countries.</s></p></div></figDesc><table><row><cell>Countries</cell><cell>Overall correlation, mean (SD)</cell><cell>Time correlation, mean (SD)</cell><cell>Cases correlation, mean (SD)</cell><cell>Deaths correlation, mean (SD)</cell></row><row><cell>All</cell><cell>0.753 (0.158)</cell><cell>0.769 (0.122)</cell><cell>0.800 (0.112)</cell><cell>0.690 (0.168)</cell></row><row><cell>Australia</cell><cell>0.641 (0.150)</cell><cell>0.701 (0.136)</cell><cell>0.732 (0.122)</cell><cell>0.495 (0.146)</cell></row><row><cell>Germany</cell><cell>0.632 (0.157)</cell><cell>0.681 (0.143)</cell><cell>0.719 (0.123)</cell><cell>0.535 (0.153)</cell></row><row><cell>Italy</cell><cell>0.753 (0.147)</cell><cell>0.772 (0.093)</cell><cell>0.819 (0.103)</cell><cell>0.796 (0.104)</cell></row><row><cell>Spain</cell><cell>0.766 (0.152)</cell><cell>0.764 (0.120)</cell><cell>0.826 (0.133)</cell><cell>0.762 (0.116)</cell></row><row><cell>UK</cell><cell>0.851 (0.066)</cell><cell>0.835 (0.052)</cell><cell>0.846 (0.037)</cell><cell>0.750 (0.075)</cell></row><row><cell>US</cell><cell>0.873 (0.058)</cell><cell>0.861 (0.047)</cell><cell>0.858 (0.024)</cell><cell>0.802 (0.056)</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p xml:id="_fszb5qM"><s xml:id="_2G5TbDx">J Med Internet Res 2020 | vol.</s><s xml:id="_j39ukwk">22 | iss. 10 | e19791 | p. 3 https://www.jmir.org/2020/10/e19791</s><s xml:id="_JRwUDK8">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_1"><p xml:id="_FvX2DZx"><s xml:id="_3PKeB6Q">J Med Internet Res 2020 | vol.</s><s xml:id="_hVMDgRV">22 | iss. 10 | e19791 | p. 4 https://www.jmir.org/2020/10/e19791(page</s><s xml:id="_n7vmUsq">number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_2"><p xml:id="_BF4pvgX"><s xml:id="_s5whqK5">J Med Internet Res 2020 | vol.</s><s xml:id="_dvzSsEx">22 | iss. 10 | e19791 | p. 5 https://www.jmir.org/2020/10/e19791</s><s xml:id="_w6Z3t6g">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_3"><p xml:id="_NJNTG3y"><s xml:id="_uNxSsz6">J Med Internet Res 2020 | vol.</s><s xml:id="_ArSjkDN">22 | iss. 10 | e19791 | p. 6 https://www.jmir.org/2020/10/e19791</s><s xml:id="_76QyTER">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_4"><p xml:id="_7ujUtKM"><s xml:id="_BS46Ap5">J Med Internet Res 2020 | vol.</s><s xml:id="_a7v5uKC">22 | iss. 10 | e19791 | p. 7 https://www.jmir.org/2020/10/e19791</s><s xml:id="_cNaBBMq">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_5"><p xml:id="_DFSXd9w"><s xml:id="_RqBMu4t">J Med Internet Res 2020 | vol.</s><s xml:id="_uBf2bYZ">22 | iss. 10 | e19791 | p. 8 https://www.jmir.org/2020/10/e19791</s><s xml:id="_P59xcnX">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_6"><p xml:id="_rqKwzQK"><s xml:id="_4BUjmzn">J Med Internet Res 2020 | vol.</s><s xml:id="_GDAjvTw">22 | iss. 10 | e19791 | p. 9 https://www.jmir.org/2020/10/e19791</s><s xml:id="_NQyfdZY">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_7"><p xml:id="_ADeJUvx"><s xml:id="_XTv4GG2">J Med Internet Res 2020 | vol.</s><s xml:id="_PYzMyDt">22 | iss. 10 | e19791 | p. 10 https://www.jmir.org/2020/10/e19791</s><s xml:id="_dnze7rj">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_8"><p xml:id="_6JzEvbh"><s xml:id="_YNzF7Wv">J Med Internet Res 2020 | vol.</s><s xml:id="_vJ4dGFz">22 | iss. 10 | e19791 | p. 11 https://www.jmir.org/2020/10/e19791</s><s xml:id="_vZM82p2">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_9"><p xml:id="_XaxTvRA"><s xml:id="_pNBkxWV">J Med Internet Res 2020 | vol.</s><s xml:id="_MTNXKb3">22 | iss. 10 | e19791 | p. 12 https://www.jmir.org/2020/10/e19791</s><s xml:id="_FTbabu5">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_10"><p xml:id="_msn2AXM"><s xml:id="_qP7AsEp">J Med Internet Res 2020 | vol.</s><s xml:id="_PzjU3Zf">22 | iss. 10 | e19791 | p. 13 https://www.jmir.org/2020/10/e19791</s><s xml:id="_TBPAeRw">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_11"><p xml:id="_U937mk8"><s xml:id="_xQwHU7b">J Med Internet Res 2020 | vol.</s><s xml:id="_AneUf9n">22 | iss. 10 | e19791 | p. 14 https://www.jmir.org/2020/10/e19791</s><s xml:id="_FYdugSc">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_12"><p xml:id="_XTtpGjk"><s xml:id="_AJ3jyVx">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_13"><p xml:id="_hb5ekjz"><s xml:id="_7MCCsES">J Med Internet Res 2020 | vol.</s><s xml:id="_DCwUY2c">22 | iss. 10 | e19791 | p. 16 https://www.jmir.org/2020/10/e19791</s><s xml:id="_s5U5ANm">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_14"><p xml:id="_JNbgqxF"><s xml:id="_Jm6tQ9p">J Med Internet Res 2020 | vol.</s><s xml:id="_7mQhWFn">22 | iss. 10 | e19791 | p. 17 https://www.jmir.org/2020/10/e19791</s><s xml:id="_zDj2TKV">(page number not for citation purposes)</s></p></note>
		</body>
		<back>

			<div type="acknowledgement">
<div><head xml:id="_VDF77pw">Acknowledgments</head><p xml:id="_BREnYzW"><s xml:id="_zGHpKM6">RABG was funded by <rs type="funder">Cardiff University</rs>.</s><s xml:id="_NY9YX4w">JPC was funded by the <rs type="funder">Biotechnology and Biological Sciences Research Council (BBSRC)</rs> through the <rs type="funder">South West Biosciences Doctoral Training Partnership</rs> (grant <rs type="grantNumber">BB/M009122/1</rs>).</s><s xml:id="_Ug657UF">BPK was funded by <rs type="funder">Idorsia Pharmaceuticals</rs>.</s><s xml:id="_RVwsk4M">HWE was funded by <rs type="funder">Cardiff University</rs>.</s><s xml:id="_4tGGNBb">Work in the ELE lab was supported by the <rs type="funder">BBSRC</rs> (<rs type="grantNumber">BB/S002774/1</rs>).</s></p></div>
			</div>
			<listOrg type="funding">
				<org type="funding" xml:id="_Na9YF5u">
					<idno type="grant-number">BB/M009122/1</idno>
				</org>
				<org type="funding" xml:id="_VAjY59e">
					<idno type="grant-number">BB/S002774/1</idno>
				</org>
			</listOrg>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_fgJcyhw">Authors' Contributions</head><p xml:id="_2WuYcAy"><s xml:id="_TAntTab">RABG and JPC cowrote the manuscript, provided sources, extracted and prepared data, performed statistical analyses, and prepared figures.</s><s xml:id="_BN6w7yJ">BPK provided sources and synthesis, and assisted with preparing the manuscript.</s><s xml:id="_TREBckZ">HWE provided data, sources, and supervision, and assisted with preparing and writing the manuscript.</s><s xml:id="_d7D4uze">ELE designed the study, provided early data searches, and contributed to writing the manuscript.</s><s xml:id="_BAGUg2r">All authors contributed to the editing of the manuscript and design of the study.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_tk4zj38">Conflicts of Interest</head><p xml:id="_wVZAWZj"><s xml:id="_Ygc3Ncr">None declared.</s><s xml:id="_r42nM7A">©Rafael A Badell-Grau, Jordan Patrick Cuff, Brendan P Kelly, Helen Waller-Evans, Emyr Lloyd-Evans.</s><s xml:id="_78u4p7z">Originally published in the Journal of Medical Internet Research (<ref type="url" target="http://www.jmir.org">http://www.jmir.org</ref>),</s><s xml:id="_m7UJbqr">27.10.2020.</s><s xml:id="_rMxjfaB">This is an open-access article distributed under the terms of the Creative Commons Attribution License (<ref type="url" target="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ref>),</s><s xml:id="_z2GDgkc">which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited.</s><s xml:id="_NnzFs3R">The complete bibliographic information, a link to the original publication on <ref type="url" target="http://www.jmir.org/">http://www.jmir.org/</ref>,</s><s xml:id="_AJxNnBd">as well as this copyright and license information must be included.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_4TgVTr2">Multimedia Appendix 1</head></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main" xml:id="_xHQByqt">Top concerns of tweeters during the COVID-19 pandemic: infoveillance study</title>
		<author>
			<persName><forename type="first">A</forename><surname>Abd-Alrazaq</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Alhuwail</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Househ</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hamdi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Shah</surname></persName>
		</author>
		<idno type="DOI">10.2196/19016</idno>
		<idno>Medline: 32287039</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_5PdabjG">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">e19016</biblScope>
			<date type="published" when="2020-04-21">2020 Apr 21</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Abd-Alrazaq A, Alhuwail D, Househ M, Hamdi M, Shah Z. Top concerns of tweeters during the COVID-19 pandemic: infoveillance study. J Med Internet Res 2020 Apr 21;22(4):e19016 [FREE Full text] [doi: 10.2196/19016] [Medline: 32287039]</note>
</biblStruct>

<biblStruct xml:id="b1">
	<monogr>
		<idno type="DOI">10.20944/preprints202007.0051.v1</idno>
		<ptr target="https://www.who.int/news-room/detail/08-04-2020-who-timeline---covid-19" />
		<title level="m" xml:id="_zpmy3Mc">WHO timeline -COVID-19</title>
		<imprint>
			<publisher>World Health Organization</publisher>
			<date type="published" when="2020-04-28">2020. 2020-04-28</date>
		</imprint>
	</monogr>
	<note type="raw_reference">WHO timeline -COVID-19. World Health Organization. 2020. URL: https://www.who.int/news-room/detail/ 08-04-2020-who-timeline---covid-19 [accessed 2020-04-28]</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_2g9bvcy">Pylons ablaze: examining the role of 5G COVID-19 conspiracy beliefs and support for violence</title>
		<author>
			<persName><forename type="first">D</forename><surname>Jolley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Paterson</surname></persName>
		</author>
		<idno type="DOI">10.1111/bjso.12394</idno>
		<idno>Medline: 32564418</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_pdMD5PQ">Br J Soc Psychol</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="628" to="640" />
			<date type="published" when="2020-07">2020 Jul</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Jolley D, Paterson JL. Pylons ablaze: examining the role of 5G COVID-19 conspiracy beliefs and support for violence. Br J Soc Psychol 2020 Jul;59(3):628-640 [FREE Full text] [doi: 10.1111/bjso.12394] [Medline: 32564418]</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_QKmpEjM">Health communication through news media during the early stage of the COVID-19 outbreak in China: digital topic modeling approach</title>
		<author>
			<persName><forename type="first">Q</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Chen</surname></persName>
		</author>
		<idno type="DOI">10.2196/19118</idno>
		<idno>Medline: 32302966</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_MQCgkpc">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">e19118</biblScope>
			<date type="published" when="2020-04-28">2020 Apr 28</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Liu Q, Zheng Z, Zheng J, Chen Q, Liu G, Chen S, et al. Health communication through news media during the early stage of the COVID-19 outbreak in China: digital topic modeling approach. J Med Internet Res 2020 Apr 28;22(4):e19118 [FREE Full text] [doi: 10.2196/19118] [Medline: 32302966]</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_U2ASb7E">Towards a more inclusive and dynamic understanding of medical mistrust informed by science</title>
		<author>
			<persName><forename type="first">J</forename><surname>Jaiswal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">N</forename><surname>Halkitis</surname></persName>
		</author>
		<idno type="DOI">10.1080/08964289.2019.1619511</idno>
		<idno>Medline: 31343962</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_85fJsDw">Behav Med</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="79" to="85" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Jaiswal J, Halkitis PN. Towards a more inclusive and dynamic understanding of medical mistrust informed by science. Behav Med 2019;45(2):79-85. [doi: 10.1080/08964289.2019.1619511] [Medline: 31343962]</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_3tvPGQw">Vaccine hesitancy and (fake) news: quasi-experimental evidence from Italy</title>
		<author>
			<persName><forename type="first">V</forename><surname>Carrieri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Madio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Principe</surname></persName>
		</author>
		<idno type="DOI">10.1002/hec.3937</idno>
		<idno>Medline: 31429153</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_QUVR9nX">Health Econ</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1377" to="1382" />
			<date type="published" when="2019-11">2019 Nov</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Carrieri V, Madio L, Principe F. Vaccine hesitancy and (fake) news: quasi-experimental evidence from Italy. Health Econ 2019 Nov;28(11):1377-1382 [FREE Full text] [doi: 10.1002/hec.3937] [Medline: 31429153]</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_s6aXeK4">The rise of post-truth populism in pluralist liberal democracies: challenges for health policy</title>
		<author>
			<persName><forename type="first">E</forename><surname>Speed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mannion</surname></persName>
		</author>
		<idno type="DOI">10.15171/ijhpm.2017.19</idno>
		<idno>Medline: 28812811</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_DtrBhxa">Int J Health Policy Manag</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="249" to="251" />
			<date type="published" when="2017-05-01">2017 May 01</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Speed E, Mannion R. The rise of post-truth populism in pluralist liberal democracies: challenges for health policy. Int J Health Policy Manag 2017 May 01;6(5):249-251 [FREE Full text] [doi: 10.15171/ijhpm.2017.19] [Medline: 28812811]</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_XPvjqcp">Infodemiology and infoveillance: framework for an emerging set of public health informatics methods to analyze search, communication and publication behavior on the Internet</title>
		<author>
			<persName><forename type="first">G</forename><surname>Eysenbach</surname></persName>
		</author>
		<idno type="DOI">10.2196/jmir.1157</idno>
		<idno>Medline: 19329408</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_avRtkzz">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">1</biblScope>
			<date type="published" when="2009-03-27">2009 Mar 27</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Eysenbach G. Infodemiology and infoveillance: framework for an emerging set of public health informatics methods to analyze search, communication and publication behavior on the Internet. J Med Internet Res 2009 Mar 27;11(1):e11 [FREE Full text] [doi: 10.2196/jmir.1157] [Medline: 19329408]</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_KyHrh6j">Google trends: a web-based tool for real-time surveillance of disease outbreaks</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Carneiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Mylonakis</surname></persName>
		</author>
		<idno type="DOI">10.1086/630200</idno>
		<idno>Medline: 19845471</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_mvP6utN">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1557" to="1564" />
			<date type="published" when="2009-11-15">2009 Nov 15</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Carneiro HA, Mylonakis E. Google trends: a web-based tool for real-time surveillance of disease outbreaks. Clin Infect Dis 2009 Nov 15;49(10):1557-1564. [doi: 10.1086/630200] [Medline: 19845471]</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_58bmzVG">Google search trends predicting disease outbreaks: an analysis from India</title>
		<author>
			<persName><forename type="first">M</forename><surname>Verma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kishore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Sondh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Aggarwal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kathirvel</surname></persName>
		</author>
		<idno type="DOI">10.4258/hir.2018.24.4.300</idno>
		<idno>Medline: 30443418</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_a5kX54H">Healthc Inform Res</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="300" to="308" />
			<date type="published" when="2018-10">2018 Oct</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Verma M, Kishore K, Kumar M, Sondh AR, Aggarwal G, Kathirvel S. Google search trends predicting disease outbreaks: an analysis from India. Healthc Inform Res 2018 Oct;24(4):300-308 [FREE Full text] [doi: 10.4258/hir.2018.24.4.300] [Medline: 30443418]</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_YMbUqMG">Use of Google Trends to investigate loss-of-smell-related searches during the COVID-19 outbreak</title>
		<author>
			<persName><forename type="first">A</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hopkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Surda</surname></persName>
		</author>
		<idno type="DOI">10.1002/alr.22580</idno>
		<idno>Medline: 32279437</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_A7HgHAW">Int Forum Allergy Rhinol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="839" to="847" />
			<date type="published" when="2020-07">2020 Jul</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Walker A, Hopkins C, Surda P. Use of Google Trends to investigate loss-of-smell-related searches during the COVID-19 outbreak. Int Forum Allergy Rhinol 2020 Jul;10(7):839-847 [FREE Full text] [doi: 10.1002/alr.22580] [Medline: 32279437]</note>
</biblStruct>

<biblStruct xml:id="b11">
	<monogr>
		<title level="m" type="main" xml:id="_8t5NJX6">EU open data portal</title>
		<idno type="DOI">10.4324/9781003138587-38</idno>
		<ptr target="https://data.europa.eu/euodp/en/data/" />
		<imprint>
			<date type="published" when="2020-04-15">2020. 2020-04-15</date>
			<publisher>European Union</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">EU open data portal. European Union. 2020. URL: https://data.europa.eu/euodp/en/data/ [accessed 2020-04-15]</note>
</biblStruct>

<biblStruct xml:id="b12">
	<monogr>
		<ptr target="https://ourworldindata.org/grapher/full-list-cumulative-total-tests-per-thousand" />
		<title level="m" xml:id="_9xSGy2m">Total COVID-19 test per 1</title>
		<imprint>
			<publisher>Our World in Data</publisher>
			<date type="published" when="2020-04-29">2020. 2020-04-29</date>
			<biblScope unit="page">0</biblScope>
		</imprint>
	</monogr>
	<note type="raw_reference">Total COVID-19 test per 1,000 people. Our World in Data. 2020. URL: https://ourworldindata.org/grapher/ full-list-cumulative-total-tests-per-thousand [accessed 2020-04-29]</note>
</biblStruct>

<biblStruct xml:id="b13">
	<monogr>
		<title level="m" type="main" xml:id="_vYTdTqM">Worldwide desktop market share of leading search engines from January 2010 to</title>
		<author>
			<persName><forename type="first">J</forename><surname>Clement</surname></persName>
		</author>
		<idno type="DOI">10.2514/6.2023-4110.vid</idno>
		<ptr target="https://www.statista.com/statistics/216573/worldwide-market-share-of-search-engines/" />
		<imprint>
			<date type="published" when="2020-04-28">July 2020. 2020. 2020-04-28</date>
			<publisher>Statista</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Clement J. Worldwide desktop market share of leading search engines from January 2010 to July 2020. Statista. 2020. URL: https://www.statista.com/statistics/216573/worldwide-market-share-of-search-engines/ [accessed 2020-04-28]</note>
</biblStruct>

<biblStruct xml:id="b14">
	<monogr>
		<idno type="DOI">10.1787/827681366000</idno>
		<ptr target="https://gs.statcounter.com/search-engine-market-share" />
		<title level="m" xml:id="_w9VmKaZ">Search engine market share worldwide</title>
		<imprint>
			<publisher>StatCounter</publisher>
			<date type="published" when="2020-04-28">2020. 2020-04-28</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Search engine market share worldwide. StatCounter. 2020. URL: https://gs.statcounter.com/search-engine-market-share [accessed 2020-04-28]</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_c4GJRns">COVID-19 breakthroughs: separating fact from fiction</title>
		<author>
			<persName><forename type="first">P</forename><surname>Dhillon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Breuer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Hirst</surname></persName>
		</author>
		<idno type="DOI">10.1111/febs.15442</idno>
		<idno>Medline: 32500928</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Jfe4Kbj">FEBS J</title>
		<imprint>
			<date type="published" when="2020-06-05">2020 Jun 05</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Dhillon P, Breuer M, Hirst N. COVID-19 breakthroughs: separating fact from fiction. FEBS J 2020 Jun 05:A [FREE Full text] [doi: 10.1111/febs.15442] [Medline: 32500928]</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_w9XqvSn">Opinion to address the personal protective equipment shortage in the global community during the COVID-19 outbreak</title>
		<author>
			<persName><forename type="first">T</forename><surname>Dargaville</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Spann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Celina</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.polymdegradstab.2020.109162</idno>
		<idno>Medline: 32292217</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_CFMpUGB">Polym Degrad Stab</title>
		<imprint>
			<biblScope unit="volume">176</biblScope>
			<biblScope unit="page">109162</biblScope>
			<date type="published" when="2020-06">2020 Jun</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Dargaville T, Spann K, Celina M. Opinion to address the personal protective equipment shortage in the global community during the COVID-19 outbreak. Polym Degrad Stab 2020 Jun;176:109162 [FREE Full text] [doi: 10.1016/j.polymdegradstab.2020.109162] [Medline: 32292217]</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_gkAy5NB">Critical supply shortages -the need for ventilators and personal protective equipment during the Covid-19 pandemic</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Ranney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Griffeth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Jha</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejmp2006141</idno>
		<idno>Medline: 32212516</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_CtDT6EE">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">382</biblScope>
			<biblScope unit="issue">18</biblScope>
			<biblScope unit="page">41</biblScope>
			<date type="published" when="2020-04-30">2020 Apr 30</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ranney ML, Griffeth V, Jha AK. Critical supply shortages -the need for ventilators and personal protective equipment during the Covid-19 pandemic. N Engl J Med 2020 Apr 30;382(18):e41. [doi: 10.1056/NEJMp2006141] [Medline: 32212516]</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_TFAdDtQ">Vaccines for COVID-19: the current state of play</title>
		<author>
			<persName><forename type="first">A</forename><surname>Koirala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">J</forename><surname>Joo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Khatami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Chiu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">N</forename><surname>Britton</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.prrv.2020.06.010</idno>
		<idno>Medline: 32653463</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Q8kZW7p">Paediatr Respir Rev</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="43" to="49" />
			<date type="published" when="2020-09">2020 Sep</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Koirala A, Joo YJ, Khatami A, Chiu C, Britton PN. Vaccines for COVID-19: the current state of play. Paediatr Respir Rev 2020 Sep;35:43-49 [FREE Full text] [doi: 10.1016/j.prrv.2020.06.010] [Medline: 32653463]</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_QNuGDNW">Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?</title>
		<author>
			<persName><forename type="first">L</forename><surname>Fang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Karakiulakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Roth</surname></persName>
		</author>
		<idno type="DOI">10.1016/s2213-2600(20)30116-8</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_35bQca3">Lancet Respir Med</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">21</biblScope>
			<date type="published" when="2020-04">2020 Apr</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 2020 Apr;8(4):e21. [doi: 10.1016/s2213-2600(20)30116-8]</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_WmRn3bJ">COVID-19 and the 5G conspiracy theory: social network analysis of Twitter data</title>
		<author>
			<persName><forename type="first">W</forename><surname>Ahmed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Vidal-Alaball</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Downing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">López</forename><surname>Seguí</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename></persName>
		</author>
		<idno type="DOI">10.2196/19458</idno>
		<idno>Medline: 32352383</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_E99ddn4">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">e19458</biblScope>
			<date type="published" when="2020-05-06">2020 May 06</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Ahmed W, Vidal-Alaball J, Downing J, López Seguí F. COVID-19 and the 5G conspiracy theory: social network analysis of Twitter data. J Med Internet Res 2020 May 06;22(5):e19458 [FREE Full text] [doi: 10.2196/19458] [Medline: 32352383]</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_83GYDPT">Is COVID-19 man-made?</title>
		<author>
			<persName><forename type="first">P</forename><surname>Chaturvedi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Ramalingam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Singh</surname></persName>
		</author>
		<idno type="DOI">10.4103/crst.crst_166_20</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_W8uSNbr">Cancer Res Stat Treat</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">284</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chaturvedi P, Ramalingam N, Singh A. Is COVID-19 man-made? Cancer Res Stat Treat 2020;3(2):284. [doi: 10.4103/crst.crst_166_20]</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_eTez47W">Uncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120 and Gag</title>
		<author>
			<persName><forename type="first">P</forename><surname>Pradhan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Pandey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mishra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Gupta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Tripathi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Menon</surname></persName>
		</author>
		<idno type="DOI">10.1101/2020.01.30.927871</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_gc5e5n9">BioRxiv</title>
		<imprint>
			<date type="published" when="2020-02-02">2020 Feb 02</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Pradhan P, Pandey AK, Mishra A, Gupta P, Tripathi PM, Menon MB, et al. Uncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120 and Gag. BioRxiv 2020 Feb 02:A. [doi: 10.1101/2020.01.30.927871]</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_VSpg8dr">-steroidal anti-inflammatory drugs (NSAIDs) for COVID-19</title>
		<idno type="DOI">10.15557/pimr.2020.0022</idno>
		<ptr target="https://www.fda.gov/drugs/drug-safety-and-availability/fda-advises-patients-use-non-steroidal-anti-inflammatory-drugs-nsaids-covid-19" />
	</analytic>
	<monogr>
		<title level="m" xml:id="_cBwM5Rw">FDA advises patients on use of non</title>
		<imprint>
			<date type="published" when="2020-03-19">2020. 2020-03-19</date>
		</imprint>
	</monogr>
	<note type="raw_reference">FDA advises patients on use of non-steroidal anti-inflammatory drugs (NSAIDs) for COVID-19. 2020. URL: https://www. fda.gov/drugs/drug-safety-and-availability/fda-advises-patients-use-non-steroidal-anti-inflammatory-drugs-nsaids-covid-19 [accessed 2020-03-19]</note>
</biblStruct>

<biblStruct xml:id="b24">
	<monogr>
		<title level="m" type="main" xml:id="_JHpzgkC">EMA gives advice on the use of non-steroidal anti-inflammatories for COVID-19</title>
		<idno type="DOI">10.1007/bf03320168</idno>
		<ptr target="https://www.ema.europa.eu/en/news/ema-gives-advice-use-non-steroidal-anti-inflammatories-covid-19" />
		<imprint>
			<date type="published" when="2020-03-18">2020 Mar 18. 2020-03-18</date>
			<publisher>European Medicines Agency</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">EMA gives advice on the use of non-steroidal anti-inflammatories for COVID-19. European Medicines Agency. 2020 Mar 18. URL: https://www.ema.europa.eu/en/news/ema-gives-advice-use-non-steroidal-anti-inflammatories-covid-19 [accessed 2020-03-18]</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_Gq2BPkF">Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19</title>
		<author>
			<persName><forename type="first">C</forename><surname>Calisher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Carroll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Colwell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Corley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Daszak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Drosten</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0140-6736(20)30418-9</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_C6Q8BUB">Lancet</title>
		<imprint>
			<biblScope unit="volume">395</biblScope>
			<biblScope unit="issue">10226</biblScope>
			<biblScope unit="page" from="42" to="e43" />
			<date type="published" when="2020-03">2020 Mar</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Calisher C, Carroll D, Colwell R, Corley RB, Daszak P, Drosten C, et al. Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19. Lancet 2020 Mar;395(10226):e42-e43. [doi: 10.1016/s0140-6736(20)30418-9]</note>
</biblStruct>

<biblStruct xml:id="b26">
	<monogr>
		<author>
			<persName><forename type="first">R</forename></persName>
		</author>
		<idno type="DOI">10.32614/r.manuals</idno>
		<ptr target="https://www.r-project.org/" />
		<title level="m" xml:id="_ZNGd9tT">A Language and Environment for Statistical Computing</title>
		<imprint/>
	</monogr>
	<note type="raw_reference">R: A Language and Environment for Statistical Computing. URL: https://www.r-project.org/</note>
</biblStruct>

<biblStruct xml:id="b27">
	<monogr>
		<title level="m" type="main" xml:id="_qzDQ3ty">ggplot2: Elegant Graphics for Data Analysis 3</title>
		<author>
			<persName><forename type="first">H</forename><surname>Wickham</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2016-06-08">Jun 08, 2016</date>
			<publisher>Springer</publisher>
			<pubPlace>New York City</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">Wickham H. ggplot2: Elegant Graphics for Data Analysis 3.3.0. New York City: Springer; Jun 08, 2016.</note>
</biblStruct>

<biblStruct xml:id="b28">
	<monogr>
		<author>
			<persName><forename type="first">E</forename><surname>Neuwirth</surname></persName>
		</author>
		<ptr target="https://cran.r-project.org/web/packages/RColorBrewer/index.html" />
		<title level="m" xml:id="_nvPGeRU">RColorBrewer: ColorBrewer Palettes R package version 1.1-2</title>
		<imprint>
			<publisher>The R Foundation</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Neuwirth E. RColorBrewer: ColorBrewer Palettes R package version 1.1-2. The R Foundation. URL: https://cran.r-project.org/ web/packages/RColorBrewer/index.html</note>
</biblStruct>

<biblStruct xml:id="b29">
	<monogr>
		<title level="m" type="main" xml:id="_kJ8qSVE">Hmisc: Harrell miscellaneous R package version 4.4-0</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">E</forename><surname>Harrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Dupont</surname></persName>
		</author>
		<ptr target="https://cran.r-project.org/web/packages/Hmisc/index.html" />
		<imprint>
			<date type="published" when="2008">2008</date>
			<publisher>The R Foundation</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Harrell FE, Dupont C. Hmisc: Harrell miscellaneous R package version 4.4-0. The R Foundation. 2008. URL: https://cran. r-project.org/web/packages/Hmisc/index.html</note>
</biblStruct>

<biblStruct xml:id="b30">
	<monogr>
		<title level="m" type="main" xml:id="_uCR3n2d">R package &quot;corrplot&quot;: visualization of a correlation matrix (version 0.84)</title>
		<author>
			<persName><forename type="first">T</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Simko</surname></persName>
		</author>
		<ptr target="https://cran.r-project.org/web/packages/corrplot/vignettes/corrplot-intro.html" />
		<imprint>
			<date type="published" when="2017">2017</date>
			<publisher>The R Foundation</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Wei T, Simko V. R package &quot;corrplot&quot;: visualization of a correlation matrix (version 0.84). The R Foundation. 2017. URL: https://cran.r-project.org/web/packages/corrplot/vignettes/corrplot-intro.html</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_74gSQ5J">default color maps from &apos;matplotlib</title>
		<author>
			<persName><forename type="first">S</forename><surname>Granier</surname></persName>
		</author>
		<author>
			<persName><surname>Viridis</surname></persName>
		</author>
		<idno type="DOI">10.32614/cran.package.viridis</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_PMC9tcE">R package version</title>
		<imprint>
			<biblScope unit="volume">0</biblScope>
			<biblScope unit="issue">5</biblScope>
		</imprint>
	</monogr>
	<note type="raw_reference">Granier S. Viridis: default color maps from &apos;matplotlib&apos;. R package version 0.5.</note>
</biblStruct>

<biblStruct xml:id="b32">
	<monogr>
		<title level="m" type="main" xml:id="_cnKerKx">Comparisons of all-cause mortality between European countries and regions: January to June 2020</title>
		<author>
			<persName><forename type="first">A</forename><surname>Campbell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Morgan</surname></persName>
		</author>
		<ptr target="https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/articles/comparisonsofallcausemortalitybetweeneuropeancountriesandregions/januarytojune2020" />
		<imprint>
			<date type="published" when="2020">2020</date>
			<publisher>Office for National Statistics</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Campbell A, Morgan E. Comparisons of all-cause mortality between European countries and regions: January to June 2020. Office for National Statistics. 2020. URL: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/ deaths/articles/comparisonsofallcausemortalitybetweeneuropeancountriesandregions/januarytojune2020</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_xeWJP4r">Opinion: coronavirus -five reasons why the UK death toll is so high</title>
		<author>
			<persName><forename type="first">J</forename><surname>Panovska-Griffiths</surname></persName>
		</author>
		<ptr target="https://www.ucl.ac.uk/news/2020/jun/opinion-coronavirus-five-reasons-why-uk-death-toll-so-high" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_5hRTSm6">UCL News</title>
		<imprint>
			<date type="published" when="2020-06-11">2020 Jun 11</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Panovska-Griffiths J. Opinion: coronavirus -five reasons why the UK death toll is so high. UCL News. 2020 Jun 11. URL: https://www.ucl.ac.uk/news/2020/jun/opinion-coronavirus-five-reasons-why-uk-death-toll-so-high</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_MQPhmnx">The wider impacts of the coronavirus pandemic on the NHS</title>
		<author>
			<persName><forename type="first">C</forename><surname>Propper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Stoye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Zaranko</surname></persName>
		</author>
		<ptr target="https://www.ifs.org.uk/publications/14798" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_nc3VnQC">Institute for Fiscal Studies</title>
		<imprint>
			<date type="published" when="2020-04-09">2020 Apr 09</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Propper C, Stoye G, Zaranko B. The wider impacts of the coronavirus pandemic on the NHS. Institute for Fiscal Studies. 2020 Apr 09. URL: https://www.ifs.org.uk/publications/14798</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_k89Mu2s">Public health emergency and crisis management: case study of SARS-CoV-2 outbreak</title>
		<author>
			<persName><forename type="first">H</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Cho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hur</surname></persName>
		</author>
		<idno type="DOI">10.3390/ijerph17113984</idno>
		<idno>Medline: 32512742</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_nChfUWS">Int J Environ Res Public Health</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page">3984</biblScope>
			<date type="published" when="2020-06-04">2020 Jun 04</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Choi H, Cho W, Kim M, Hur J. Public health emergency and crisis management: case study of SARS-CoV-2 outbreak. Int J Environ Res Public Health 2020 Jun 04;17(11):3984 [FREE Full text] [doi: 10.3390/ijerph17113984] [Medline: 32512742]</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_5VzWvfQ">Covid-19: why Germany&apos;s case fatality rate seems so low</title>
		<author>
			<persName><forename type="first">N</forename><surname>Stafford</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.m1395</idno>
		<idno>Medline: 32265194</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_D4Ju5Ub">BMJ</title>
		<imprint>
			<biblScope unit="volume">369</biblScope>
			<biblScope unit="page">1395</biblScope>
			<date type="published" when="2020-04-07">2020 Apr 07</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Stafford N. Covid-19: why Germany&apos;s case fatality rate seems so low. BMJ 2020 Apr 07;369:m1395. [doi: 10.1136/bmj.m1395] [Medline: 32265194]</note>
</biblStruct>

<biblStruct xml:id="b37">
	<monogr>
		<idno type="DOI">10.32614/cran.package.coronavirus</idno>
		<ptr target="https://www.health.gov.au/news/health-alerts/novel-coronavirus-2019-ncov-health-alert/coronavirus-covid-19-restrictions/coronavirus-covid-19-advice-for-international-travellers41" />
		<title level="m" xml:id="_6JdVfjq">Coronavirus (COVID-19) advice for international travellers</title>
		<imprint>
			<publisher>Australian Government</publisher>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Coronavirus (COVID-19) advice for international travellers. Australian Government. 2020. URL: https://www.health.gov.au/ news/health-alerts/novel-coronavirus-2019-ncov-health-alert/coronavirus-covid-19-restrictions/ coronavirus-covid-19-advice-for-international-travellers 41</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main" xml:id="_RCyNrez">COVID-19</title>
		<idno type="DOI">10.33321/cdi.2020.44.34</idno>
		<idno>Medline: 32299330</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_4qjdEMM">Commun Dis Intell</title>
		<imprint>
			<date type="published" when="2018">2018. 2020 Apr 17:44</date>
			<pubPlace>Australia</pubPlace>
		</imprint>
		<respStmt>
			<orgName>National Incident Room Surveillance Team</orgName>
		</respStmt>
	</monogr>
	<note>COVID-19 epidemiology report 11 (reporting week to 23:59 AEST 12 April 2020</note>
	<note type="raw_reference">COVID-19 National Incident Room Surveillance Team. COVID-19, Australia: epidemiology report 11 (reporting week to 23:59 AEST 12 April 2020). Commun Dis Intell (2018) 2020 Apr 17:44. [doi: 10.33321/cdi.2020.44.34] [Medline: 32299330]</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main" xml:id="_e9qj7qJ">Coronavirus: the world in lockdown in maps and charts</title>
		<author>
			<persName><forename type="first">D</forename><surname>Dunford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Dale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Stylianou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Lowther</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ahmed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Torre</forename><surname>De La</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Arenas</surname></persName>
		</author>
		<ptr target="https://www.bbc.co.uk/news/world-52103747" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_hKSJXgd">BBC News</title>
		<imprint>
			<date type="published" when="2020-04-07">2020 Apr 07</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dunford D, Dale B, Stylianou N, Lowther E, Ahmed M, de la Torre Arenas I. Coronavirus: the world in lockdown in maps and charts. BBC News. 2020 Apr 07. URL: https://www.bbc.co.uk/news/world-52103747</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main" xml:id="_3M99hbP">Coping and tolerance of uncertainty: predictors and mediators of mental health during the COVID-19 pandemic</title>
		<author>
			<persName><forename type="first">H</forename><surname>Rettie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Daniels</surname></persName>
		</author>
		<idno type="DOI">10.1037/amp0000710</idno>
		<idno>Medline: 32744841</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_efMKvw4">Am Psychol</title>
		<imprint>
			<date type="published" when="2020-08-03">2020 Aug 03</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Rettie H, Daniels J. Coping and tolerance of uncertainty: predictors and mediators of mental health during the COVID-19 pandemic. Am Psychol 2020 Aug 03:A. [doi: 10.1037/amp0000710] [Medline: 32744841]</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main" xml:id="_H6EBxQ2">Psychological symptoms during the two stages of lockdown in response to the COVID-19 outbreak: an investigation in a sample of citizens in Northern Spain</title>
		<author>
			<persName><forename type="first">N</forename><surname>Ozamiz-Etxebarria</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Idoiaga</forename><surname>Mondragon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Dosil</forename><surname>Santamaría</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Picaza</forename><surname>Gorrotxategi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
		<idno type="DOI">10.3389/fpsyg.2020.01491</idno>
		<idno>Medline: 32625157</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_EWxKzZ8">Front Psychol</title>
		<imprint/>
	</monogr>
	<note type="raw_reference">Ozamiz-Etxebarria N, Idoiaga Mondragon N, Dosil Santamaría M, Picaza Gorrotxategi M. Psychological symptoms during the two stages of lockdown in response to the COVID-19 outbreak: an investigation in a sample of citizens in Northern Spain. Front Psychol [doi: 10.3389/fpsyg.2020.01491] [Medline: 32625157]</note>
</biblStruct>

<biblStruct xml:id="b42">
	<monogr>
		<title level="m" type="main" xml:id="_xSV7bqg">What do world leaders really mean by refusing to wear face masks? The University of Edinburgh</title>
		<author>
			<persName><forename type="first">C</forename><surname>Pagliari</surname></persName>
		</author>
		<ptr target="https://www.ed.ac.uk/covid-19-response/expert-insights/what-messages-are-world-leaders-giving-when-they-r" />
		<imprint>
			<date type="published" when="2020-06-17">2020 Jun 17</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Pagliari C. What do world leaders really mean by refusing to wear face masks? The University of Edinburgh. 2020 Jun 17. URL: https://www.ed.ac.uk/covid-19-response/expert-insights/what-messages-are-world-leaders-giving-when-they-r</note>
</biblStruct>

<biblStruct xml:id="b43">
	<monogr>
		<title level="m" type="main" xml:id="_qbJU8Mt">Italy imposes draconian rules to stop spread of coronavirus</title>
		<author>
			<persName><forename type="first">A</forename><surname>Giuffrida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cochrane</surname></persName>
		</author>
		<ptr target="https://www.theguardian.com/world/2020/feb/23/italy-draconian-measures-effort-halt-coronavirus-outbreak-spread" />
		<imprint>
			<date type="published" when="2020-02-23">2020 Feb 23</date>
			<publisher>The Guardian</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Giuffrida A, Cochrane L. Italy imposes draconian rules to stop spread of coronavirus. The Guardian. 2020 Feb 23. URL: https://www.theguardian.com/world/2020/feb/23/italy-draconian-measures-effort-halt-coronavirus-outbreak-spread</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main" xml:id="_W8QsjgW">Lockdown timing and efficacy in controlling COVID-19 using mobile phone tracking</title>
		<author>
			<persName><forename type="first">M</forename><surname>Vinceti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Filippini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Rothman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ferrari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Goffi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Maffeis</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.eclinm.2020.100457</idno>
		<idno>Medline: 32838234</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_PVSyt6H">EClinicalMedicine</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page">100457</biblScope>
			<date type="published" when="2020-08">2020 Aug</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Vinceti M, Filippini T, Rothman K, Ferrari F, Goffi A, Maffeis G, et al. Lockdown timing and efficacy in controlling COVID-19 using mobile phone tracking. EClinicalMedicine 2020 Aug;25:100457 [FREE Full text] [doi: 10.1016/j.eclinm.2020.100457] [Medline: 32838234]</note>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main" xml:id="_EFB28V6">Let us unite against COVID-19 -a New Zealand perspective</title>
		<author>
			<persName><forename type="first">G</forename><surname>Bandyopadhyay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Meltzer</surname></persName>
		</author>
		<idno type="DOI">10.1017/ipm.2020.44</idno>
		<idno>Medline: 32404225</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_3Fjgtmw">Ir J Psychol Med</title>
		<imprint>
			<biblScope unit="page" from="1" to="4" />
			<date type="published" when="2020-05-14">2020 May 14</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Bandyopadhyay G, Meltzer A. Let us unite against COVID-19 -a New Zealand perspective. Ir J Psychol Med 2020 May 14:1-4 [FREE Full text] [doi: 10.1017/ipm.2020.44] [Medline: 32404225]</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main" xml:id="_peEzexS">Ibuprofen during the COVID-19 pandemic: social media precautions and implications</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Carius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Schauer</surname></persName>
		</author>
		<idno type="DOI">10.5811/westjem.2020.4.47686</idno>
		<idno>Medline: 32421496</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_QRVYwQm">West J Emerg Med</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="497" to="498" />
			<date type="published" when="2020-04-24">2020 Apr 24</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Carius BM, Schauer SG. Ibuprofen during the COVID-19 pandemic: social media precautions and implications. West J Emerg Med 2020 Apr 24;21(3):497-498 [FREE Full text] [doi: 10.5811/westjem.2020.4.47686] [Medline: 32421496]</note>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main" xml:id="_Q3gJTdy">Time-trend analysis of medicine sales and shortages during COVID-19 outbreak: data from community pharmacies</title>
		<author>
			<persName><forename type="first">S</forename><surname>Romano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Galante</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Figueira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Mendes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">T</forename><surname>Rodrigues</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.sapharm.2020.05.024</idno>
		<idno>Medline: 32482587</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_zfjTbPa">Res Social Adm Pharm</title>
		<imprint>
			<biblScope unit="page" from="30611" to="30612" />
			<date type="published" when="2020-05-23">2020 May 23</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Romano S, Galante H, Figueira D, Mendes Z, Rodrigues AT. Time-trend analysis of medicine sales and shortages during COVID-19 outbreak: data from community pharmacies. Res Social Adm Pharm 2020 May 23:30611-30612 [FREE Full text] [doi: 10.1016/j.sapharm.2020.05.024] [Medline: 32482587]</note>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main" xml:id="_urt2uVJ">Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro</title>
		<author>
			<persName><forename type="first">M</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Cao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Xu</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41422-020-0282-0</idno>
		<idno>Medline: 32020029</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_x3jTwUV">Cell Res</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="269" to="271" />
			<date type="published" when="2020-03">2020 Mar</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020 Mar;30(3):269-271 [FREE Full text] [doi: 10.1038/s41422-020-0282-0] [Medline: 32020029]</note>
</biblStruct>

<biblStruct xml:id="b49">
	<monogr>
		<author>
			<persName><forename type="first">C</forename><surname>Flanagan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Griffin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Langreth</surname></persName>
		</author>
		<ptr target="https://www.bloomberg.com/features/2020-coronavirus-drug-vaccine-status/" />
		<title level="m" xml:id="_V2su9an">The race to develop coronavirus treatments and vaccines is heating up</title>
		<imprint>
			<publisher>Bloomberg</publisher>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Flanagan C, Griffin R, Langreth R. The race to develop coronavirus treatments and vaccines is heating up. Bloomberg. 2020. URL: https://www.bloomberg.com/features/2020-coronavirus-drug-vaccine-status/</note>
</biblStruct>

<biblStruct xml:id="b50">
	<monogr>
		<title level="m" type="main" xml:id="_PbfVn66">Oxford COVID-19 vaccine programme opens for clinical trial recruitment</title>
		<idno>COVID-19</idno>
		<ptr target="https://covid19vaccinetrial.co.uk/press-release-trial-open" />
		<imprint>
			<date type="published" when="2020-03-27">2020 Mar 27</date>
			<publisher>Oxford Vaccine Trial</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Oxford COVID-19 vaccine programme opens for clinical trial recruitment. COVID-19 Oxford Vaccine Trial. 2020 Mar 27. URL: https://covid19vaccinetrial.co.uk/press-release-trial-open</note>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main" xml:id="_87QEVxF">Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Sattui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Liew</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">R</forename><surname>Graef</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Coler-Reilly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Berenbaum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Duarte-García</surname></persName>
		</author>
		<idno type="DOI">10.1080/1744666X.2020.1792778</idno>
		<idno>Medline: 32620062</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_XjXzeYQ">Expert Rev Clin Immunol</title>
		<imprint>
			<biblScope unit="page" from="1" to="8" />
			<date type="published" when="2020-08-11">2020 Aug 11</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sattui SE, Liew JW, Graef ER, Coler-Reilly A, Berenbaum F, Duarte-García A, et al. Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19. Expert Rev Clin Immunol 2020 Aug 11:1-8. [doi: 10.1080/1744666X.2020.1792778] [Medline: 32620062]</note>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main" xml:id="_nWkWUpv">Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial</title>
		<author>
			<persName><forename type="first">P</forename><surname>Gautret</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lagier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Parola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">T</forename><surname>Hoang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Meddeb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mailhe</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ijantimicag.2020.105949</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_6bmXCv2">Int J Antimicrob Agents</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">105949</biblScope>
			<date type="published" when="2020-07">2020 Jul</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gautret P, Lagier J, Parola P, Hoang VT, Meddeb L, Mailhe M, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020 Jul;56(1):105949. [doi: 10.1016/j.ijantimicag.2020.105949]</note>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main" xml:id="_2pArEcg">Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial</title>
		<author>
			<persName><forename type="first">Mgs</forename><surname>Borba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ffa</forename><surname>Val</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">S</forename><surname>Sampaio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Maa</forename><surname>Alexandre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Melo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Brito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Clorocovid-19</forename><surname>Team</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamanetworkopen.2020.8857</idno>
		<idno>Medline: 32330277</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ptKUndz">JAMA Netw Open</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">208857</biblScope>
			<date type="published" when="2020-04-24">2020 Apr 24</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Borba MGS, Val FFA, Sampaio VS, Alexandre MAA, Melo GC, Brito M, CloroCovid-19 Team. Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial. JAMA Netw Open 2020 Apr 24;3(4):e208857 [FREE Full text] [doi: 10.1001/jamanetworkopen.2020.8857] [Medline: 32330277]</note>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main" xml:id="_p9HjsUJ">Hydroxychloroquine for covid-19: the end of the line?</title>
		<author>
			<persName><forename type="first">E</forename><surname>Mahase</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.m2378</idno>
		<idno>Medline: 32540958</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_8HTMksp">BMJ</title>
		<imprint>
			<biblScope unit="volume">369</biblScope>
			<biblScope unit="page">2378</biblScope>
			<date type="published" when="2020-06-15">2020 Jun 15</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mahase E. Hydroxychloroquine for covid-19: the end of the line? BMJ 2020 Jun 15;369:m2378. [doi: 10.1136/bmj.m2378] [Medline: 32540958]</note>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main" xml:id="_QtYwKVY">Intentional hydroxychloroquine overdose treated with high-dose diazepam: an increasing concern in the COVID-19 pandemic</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Chai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">G</forename><surname>Ferro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Kirshenbaum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Hayes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Culbreth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">W</forename><surname>Boyer</surname></persName>
		</author>
		<idno type="DOI">10.1007/s13181-020-00790-8</idno>
		<idno>Medline: 32514696</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qqvVCS5">J Med Toxicol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="314" to="320" />
			<date type="published" when="2020-07">2020 Jul</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Chai PR, Ferro EG, Kirshenbaum JM, Hayes BD, Culbreth SE, Boyer EW, et al. Intentional hydroxychloroquine overdose treated with high-dose diazepam: an increasing concern in the COVID-19 pandemic. J Med Toxicol 2020 Jul;16(3):314-320 [FREE Full text] [doi: 10.1007/s13181-020-00790-8] [Medline: 32514696]</note>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main" xml:id="_wAge9hV">Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents</title>
		<author>
			<persName><forename type="first">G</forename><surname>Kampf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Todt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Pfaender</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Steinmann</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jhin.2020.01.022</idno>
		<idno>Medline: 32035997</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_6pG7AWV">J Hosp Infect</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="246" to="251" />
			<date type="published" when="2020-03">2020 Mar</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect 2020 Mar;104(3):246-251 [FREE Full text] [doi: 10.1016/j.jhin.2020.01.022] [Medline: 32035997]</note>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main" xml:id="_fkEbPfp">Spike in poison control calls related to disinfectant exposures</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Kuehn</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.2020.8307</idno>
		<idno>Medline: 32515822</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_K7x5UUx">JAMA</title>
		<imprint>
			<biblScope unit="volume">323</biblScope>
			<biblScope unit="issue">22</biblScope>
			<biblScope unit="page">2240</biblScope>
			<date type="published" when="2020-06-09">2020 Jun 09</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kuehn BM. Spike in poison control calls related to disinfectant exposures. JAMA 2020 Jun 09;323(22):2240. [doi: 10.1001/jama.2020.8307] [Medline: 32515822]</note>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main" xml:id="_dmb62nu">Rapid inactivation of SARS-CoV-2 with deep-UV LED irradiation</title>
		<author>
			<persName><forename type="first">H</forename><surname>Inagaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Saito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Sugiyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Okabayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fujimoto</surname></persName>
		</author>
		<idno type="DOI">10.1080/22221751.2020.1796529</idno>
		<idno>Medline: 32673522</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_hEKanU3">Emerg Microbes Infect</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1744" to="1747" />
			<date type="published" when="2020-12">2020 Dec</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Inagaki H, Saito A, Sugiyama H, Okabayashi T, Fujimoto S. Rapid inactivation of SARS-CoV-2 with deep-UV LED irradiation. Emerg Microbes Infect 2020 Dec;9(1):1744-1747 [FREE Full text] [doi: 10.1080/22221751.2020.1796529] [Medline: 32673522]</note>
</biblStruct>

<biblStruct xml:id="b59">
	<monogr>
		<title level="m" type="main" xml:id="_NeSnPMu">Types, sources, and claims of COVID-19 misinformation</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Brennen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Simon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">N</forename><surname>Howard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Nielsen</surname></persName>
		</author>
		<idno type="DOI">10.1177/1940161220964780</idno>
		<ptr target="https://reutersinstitute.politics.ox.ac.uk/types-sources-and-claims-covid-19-misinformation" />
		<imprint>
			<date type="published" when="2020-04-07">2020 Apr 07</date>
			<publisher>Reuters Institute</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Brennen JS, Simon F, Howard PN, Nielsen RK. Types, sources, and claims of COVID-19 misinformation. Reuters Institute. 2020 Apr 07. URL: https://reutersinstitute.politics.ox.ac.uk/types-sources-and-claims-covid-19-misinformation</note>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main" xml:id="_HVAaQ5k">Early in the epidemic: impact of preprints on global discourse about COVID-19 transmissibility</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Majumder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Mandl</surname></persName>
		</author>
		<idno type="DOI">10.1016/s2214-109x(20)30113-3</idno>
		<idno>Medline: 32220289</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Tsx8nfd">Lancet Glob Health</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="627" to="e630" />
			<date type="published" when="2020-05">2020 May</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Majumder MS, Mandl KD. Early in the epidemic: impact of preprints on global discourse about COVID-19 transmissibility. Lancet Glob Health 2020 May;8(5):e627-e630 [FREE Full text] [doi: 10.1016/S2214-109X(20)30113-3] [Medline: 32220289]</note>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main" xml:id="_kgym23Z">A Google Trends study on the interest in self-medication during the 2019 novel coronavirus (COVID-19) disease pandemic</title>
		<author>
			<persName><forename type="first">D</forename><surname>Onchonga</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jsps.2020.06.007</idno>
		<idno>Medline: 32641903</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_KEwRE3A">Saudi Pharm J</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="903" to="904" />
			<date type="published" when="2020-07">2020 Jul</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Onchonga D. A Google Trends study on the interest in self-medication during the 2019 novel coronavirus (COVID-19) disease pandemic. Saudi Pharm J 2020 Jul;28(7):903-904 [FREE Full text] [doi: 10.1016/j.jsps.2020.06.007] [Medline: 32641903]</note>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main" xml:id="_Paxhyvt">Correlations of online search engine trends with coronavirus disease (COVID-19) incidence: infodemiology study</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename><surname>Higgins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Illing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Rubel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Ting</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Force</forename><surname>Snot</surname></persName>
		</author>
		<author>
			<persName><surname>Alliance</surname></persName>
		</author>
		<idno type="DOI">10.2196/19702</idno>
		<idno>Medline: 32401211</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_dG9whbJ">JMIR Public Health Surveill</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">e19702</biblScope>
			<date type="published" when="2020-05-21">2020 May 21</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Higgins TS, Wu AW, Sharma D, Illing EA, Rubel K, Ting JY, Snot Force Alliance. Correlations of online search engine trends with coronavirus disease (COVID-19) incidence: infodemiology study. JMIR Public Health Surveill 2020 May 21;6(2):e19702 [FREE Full text] [doi: 10.2196/19702] [Medline: 32401211]</note>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main" xml:id="_NFmR3A6">Is Google Trends a reliable tool for digital epidemiology? Insights from different clinical settings</title>
		<author>
			<persName><forename type="first">G</forename><surname>Cervellin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Comelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Lippi</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jegh.2017.06.001</idno>
		<idno>Medline: 28756828</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_DrwFSsE">J Epidemiol Glob Health</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="185" to="189" />
			<date type="published" when="2017-09">2017 Sep</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Cervellin G, Comelli I, Lippi G. Is Google Trends a reliable tool for digital epidemiology? Insights from different clinical settings. J Epidemiol Glob Health 2017 Sep;7(3):185-189 [FREE Full text] [doi: 10.1016/j.jegh.2017.06.001] [Medline: 28756828]</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
